プロテオミクス市場規模、シェア、動向、2030年までの世界予測

世界のプロテオミクス市場は、2025年の363億2000万米ドルから2030年には657億8000万米ドルに成長し、2025年から2030年までの年平均成長率（CAGR）は12.6%に達するとMarketsandMarketsでは予測しています。

腫瘍学、免疫学、その他の複雑な疾患におけるプロテオミクスの利用の増加は、世界中の研究所でタンパク質プロファイリングの日常的な需要を高めています。製薬およびバイオテクノロジーのチームは、バイオマーカープログラムを拡大し、より大規模なトランスレーショナルコホートを実施しており、LC-MSワークフロー、ターゲットパネル、標準化されたサンプル調製に対するスループットのニーズが高まっています。

調査範囲：

本調査レポートは、プロテオミクス市場を機器技術別に分類しています。機器技術：分光法（質量分析法、NMR分光法、CD分光法）、クロマトグラフィー（高速液体クロマトグラフィー、イオンクロマトグラフィー、アフィニティークロマトグラフィー、超臨界流体クロマトグラフィー）、電気泳動法（ゲル電気泳動、キャピラリー電気泳動）、タンパク質マイクロアレイ（バイオチップ、マイクロアレイ装置）、X線結晶構造解析、表面プラズモン共鳴、タンパク質分画、その他の機器技術。試薬別：免疫測定試薬、分光試薬、クロマトグラフィー試薬、タンパク質マイクロアレイ試薬、X線結晶構造解析試薬、電気泳動試薬、タンパク質分画試薬、その他の試薬。サービス別：コアプロテオミクスサービス（タンパク質同定サービス、定量プロテオミクスサービス、タンパク質特性評価サービス、タンパク質精製サービス、タンパク質分離サービス、タンパク質シーケンスサービス、カスタムアッセイサービス）、バイオインフォマティクスサービス。ソフトウェア別：バイオインフォマティクスツール、バイオインフォマティクスデータベース。アプリケーション別：臨床診断（がん、感染症、糖尿病、神経疾患、自己免疫疾患、心血管疾患、その他の臨床診断アプリケーション）、創薬・開発（標的発見、リード同定、リード最適化、前臨床試験）、その他のアプリケーション。エンドユーザー別：バイオ医薬品企業、学術機関・研究機関、病院、臨床検査機関、その他のエンドユーザー、地域別（北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東、アフリカ）。本レポートの範囲は、プロテオミクス市場の成長に影響を与える推進要因、課題、機会、制約などの主要要因に関する詳細情報を網羅しています。本レポートでは、主要な業界プレーヤーの詳細な分析を行い、事業概要、製品ポートフォリオ、製品発売、提携、パートナーシップ、事業拡大、契約などの主要戦略、およびプロテオミクス市場に関連する最近の動向に関する洞察を提供します。また、プロテオミクス市場のエコシステムにおけるトッププレーヤーと新興スタートアップの競合分析も網羅しています。

本レポートを購入する主なメリット：

本レポートは、プロテオミクス市場全体およびそのサブセグメントの収益予測を最も正確に提供することで、市場リーダーや新規参入企業を支援します。また、関係者が競争環境をより深く理解し、事業のポジショニングを改善し、適切な市場参入戦略を策定するための洞察を得るのに役立ちます。さらに、市場の動向を把握し、主要な市場推進要因、阻害要因、機会、課題に関する情報を提供します。

本レポートは、以下のポイントに関する洞察を提供します。

市場の成長に影響を与える主要な推進要因（腫瘍学およびプロテオゲノミクスプログラムからの強い需要、マルチオミクスの成長）、阻害要因（総所有コストの高さ）、機会（シングルセルおよび低インプットプロテオミクス、発見を加速するクラウドおよび共有データプラットフォーム）、課題（データ量、データ解釈、バイオインフォマティクスのボトルネック）の分析。

• 製品開発／イノベーション：プロテオミクス市場における新製品およびサービスの詳細な分析。
• 市場開発：有望な市場に関する包括的な情報 ― 本レポートは、様々な地域における市場を分析しています。
• 市場の多様化：プロテオミクス市場における新製品、未開拓地域、最新動向、投資に関する包括的な情報。
• 競合分析：サーモフィッシャーサイエンティフィック（米国）、ダナハーコーポレーション（米国）、アジレントテクノロジー（米国）、バイオ・ラッド・ラボラトリーズ（米国）、レヴィティ（米国）、イルミナ（米国）、プロメガ（米国）、チャールズ・リバー・ラボラトリーズ（米国）など。

Report Description

The global proteomics market is projected to reach USD 65.78 billion by 2030 from USD 36.32 billion in 2025, at a CAGR of 12.6% from 2025 to 2030.  Rising use of proteomics in oncology, immunology and other complex diseases is pushing higher routine demand for protein profiling across global labs. Pharma and biotech teams are expanding biomarker programs and running larger translational cohorts, which increases throughput needs for LC-MS workflows, targeted panels, and standardized sample preparation.

“The immunoassay reagents segment accounted for the largest share by reagent in the proteomics market in 2024”

Based on reagent, the proteomics market is segmented into, protein microarray reagents, spectroscopy reagents, X-ray crystallography reagents, chromatography reagents, electrophoresis reagents, immunoassay reagents, and protein fractionation reagents. The immunoassay reagents dominated the reagent segment; however spectroscopy reagent is anticipated to grow at significant CAGR during the forecast period. Factors like growing use of mass spectrometry-based techniques, development of high-throughput mass spectrometry techniques, increasing interest in personalized medicine and biomarker discovery are likely to drive the segmental growth.

“The biopharmaceutical companies segment accounted for the largest share by end user segment in the proteomics market in 2024”

Based on end user, the proteomics market is segmented into hospitals, clinical laboratories, biopharmaceutical companies, academic & research institutes, and other end users. The biopharmaceutical companies segment dominated the proteomics market owing to the rising focus of pharma giants on core activities like increasing R&D for the discovery and development of new molecules.

“The Asia Pacific region is growing at the highest CAGR in the proteomics market from 2025 to 2030.”

Geographically, the proteomics market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. In 2023, North America accounted for the major share of the proteomics market. The Asia Pacific region is likely to grow at significant CAGR during the forecast period owing to various factors such as growing fields of proteomics and genomics research in conjunction with an increase in funding toward research studies. Rising investment by biopharmaceutical companies, growing research activity in the area of mAb-based therapeutics are likely to drive market expansion in the region.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1- 40%, Tier 2- 30% and Tier 3- 30%
• By Designation: Directors- 20%, Managers- 10% and Others – 70%,
• By Region: North America -35%, Europe -25%, Asia-Pacific -25%, Latin America -10%, and Middle East -5%.

List of Companies Profiled in the Report:

• Thermo fisher Scientific Inc (US)
• Agilent Technologies, Inc. (US)
• Merck KGaA (Germany)
• Danaher Corporation (US)
• Waters Corporation (US)
• Bio-Rad Laboratories, Inc. (US)
• Bruker Corporation (US)
• Revvity (US)
• Shimadzu Corporation (Japan)
• Illumina Inc (US)
• Promega Corporation (US)
• Eurofins Scientific (Luxembourg)
• Qiagen (Netherlands)
• Charles River Laboratories (US)
• Protagene (Germany)
• Creative Proteomics (US)
• Horiba (Japan)
• Sengenics Corporation LLC (US)
• Labvantage-Biomax GmbH (Germany)
• Cell Signaling Technology, Inc. (US)
• FIOS Genomics (UK)
• Azenta Life Sciences (US)
• Medgenome (India)
• Biognosys AG (Switzerland)
• Macrogen Inc (South Korea)

Research Coverage:

This research report categorizes the proteomics market by Instrumentation Technology : Spectroscopy (Mass spectroscopy, NMR spectroscopy, CD spectroscopy),  Chromatography (High performance liquid chromatography, Ion chromatography, Affininty chromatography, Supercritical fluid chromatography), Electrophoresis (Gel electrophoresis, Capillary electrophoresis), Protein Microarrays (Biochips, Microarray instruments), X ray Crystallography, Surface Plasmon Resonance , Protein fractionation, Other intrumentation technologies; by reagent: Immunoassay reagents, spectroscopy reagents, chromatography reagents, protein microarray reagents, X‑ray crystallography reagents, electrophoresis reagents, protein fractionation reagents, other reagents; by Service: Core proteomics services (Protein indentification services, Quantitative proteomics services, Protein characterization services, Protein purification services, Protein separation services, Protein sequencing services, Custom assay services), Bioinformatics services; by software: Bioinformatics Tools, Bioinformatics databases; by Application: Clinical Diagnostics (Cancer, Infectious diseases, Diabetes, Neurological disorders, Autoimmune diseases, Cardiovascular diseases, Other clinical diagnostic applications), Drug discovery & Development (Target discovery, Lead identification, Lead optimization, Preclinical studies), Other applications; by End User: Biopharmaceutical Companies, Academic Institutes & Research Institutes, Hospitals, Clinical laboratories, Other end users and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints, influencing the growth of the proteomics market. A detailed analysis of the key industry players has been done to provide insights into their business overview, product portfolio, key strategies such as product launches, collaborations, partnerships, expansions, agreements, and recent developments associated with the proteomics market. Competitive analysis of top players and upcoming startups in the proteomics market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall proteomics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (Strong pull from oncology and proteogenomics programs, Growth in multi-omics), restraints (High total cost of ownership), opportunities (Single-cell and low-input proteomics, Cloud and shared data platforms to accelerate discovery), and challenges (Data volume, interpretation and bioinformatics bottlenecks) influencing the growth of the market.

• Product Development/Innovation: Detailed insights on newly launched products and services of the proteomics market
• Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the proteomics market
• Competitive Assessment: Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc. (US), Bio‑Rad Laboratories (US), Revvity (US), Illumina Inc. (US), Promega Corporation (US) and Charles River Laboratories (US), among others.

Table of Contents

1 INTRODUCTION 78
1.1 STUDY OBJECTIVES 78
1.2 MARKET DEFINITION 78
1.3 STUDY SCOPE 78
1.3.1 MARKET SEGMENTATION AND REGIONS COVERED 79
1.3.2 INCLUSIONS & EXCLUSIONS 80
1.3.3 YEARS CONSIDERED 81
1.3.4 CURRENCY CONSIDERED 81
1.4 STAKEHOLDERS 82
1.5 SUMMARY OF CHANGES 82
2 EXECUTIVE SUMMARY 83
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 83
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 84
2.3 DISRUPTIVE TRENDS IN PROTEOMICS MARKET 85
2.4 HIGH-GROWTH SEGMENTS 86
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 87
3 PREMIUM INSIGHTS 88
3.1 PROTEOMICS MARKET OVERVIEW 88
3.2 NORTH AMERICA: PROTEOMICS MARKET, BY SERVICE 89
3.3 PROTEOMICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 89
3.4 PROTEOMICS MARKET SHARE, BY APPLICATION, 2026 VS 2031 (%) 90
4 MARKET OVERVIEW 91
4.1 INTRODUCTION 91
4.2 MARKET DYNAMICS 92
4.2.1 DRIVERS 93
4.2.1.1 Advancements in DIA and high-throughput mass spectrometry 93
4.2.1.2 Growing clinical and plasma proteomics adoption for biomarker discovery and translational diagnostics 93
4.2.1.3 Rising integration of proteomics with multi-omics workflows 94
4.2.1.4 Expansion of automation and low-input proteomics workflows 94
4.2.2 RESTRAINTS 94
4.2.2.1 High capital intensity of high-resolution mass spectrometry platforms 94
4.2.2.2 Complexity of proteomics data analysis 95
4.2.3 OPPORTUNITIES 95
4.2.3.1 Emergence of single-cell proteomics for high-resolution cellular profiling 95
4.2.3.2 Expansion of spatial proteomics in tissue-context biology and biomarker research 95
4.2.3.3 Adoption of AI-enabled proteomics informatics 96
4.2.4 CHALLENGES 96
4.2.4.1 Limited detection of low-abundance proteins 96
4.2.4.2 Lack of standardization across workflows 97
4.3 UNMET NEEDS AND WHITE SPACES 97
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 98
4.5 STRATEGIC MOVIES BY TIER-1/2/3 PLAYERS 99
5 INDUSTRY TRENDS 100
5.1 PORTER’S FIVE FORCES ANALYSIS 100
5.1.1 INTENSITY OF COMPETITIVE RIVALRY 101
5.1.2 BARGAINING POWER OF SUPPLIERS 101
5.1.3 BARGAINING POWER OF BUYERS 101
5.1.4 THREAT OF SUBSTITUTES 101
5.1.5 THREAT OF NEW ENTRANTS 101
5.2 MACROECONOMIC OUTLOOK 102
5.2.1 INTRODUCTION 102
5.2.2 GDP TRENDS AND FORECAST 102
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 102
5.2.4 TRENDS IN GLOBAL BIOTECH INDUSTRY 103
5.3 VALUE CHAIN ANALYSIS 104
5.4 ECOSYSTEM ANALYSIS 105
5.4.1 ROLE OF PLAYERS IN ECOSYSTEM 106
5.5 PRICING ANALYSIS 107
5.5.1 AVERAGE SELLING PRICE TREND, KEY PLAYER, 2023-2025 108
5.5.1.1 Instrumentation 108
5.5.1.2 Reagents 109
5.5.2 AVERAGE SELLING PRICE TREND, BY REGION, 2023–2025 109
5.5.2.1 Instrumentation 109
5.5.3 REAGENTS 110
5.6 TRADE ANALYSIS 111
5.6.1 IMPORT SCENARIO (HS CODE 9027.20) 111
5.6.2 EXPORT SCENARIO (HS CODE 9027.20) 112
5.6.3 IMPORT SCENARIO (HS CODE 9027.81) 112
5.6.4 EXPORT SCENARIO (HS CODE 9027.81) 113
5.7 KEY CONFERENCES & EVENTS, 2026–2027 114
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 114
5.9 INVESTMENT & FUNDING SCENARIO 115

5.10 CASE STUDY ANALYSIS 116
5.10.1 PLASMA PROTEOMICS IMPROVES RISK PREDICTION ACROSS MULTIPLE DISEASES 116
5.10.2 PLASMA PROTEOMICS SUPPORTS ALS BIOMARKER DISCOVERY 116
5.10.3 AI-ENABLED PROTEOMICS ADVANCES DEMENTIA DIAGNOSTICS 117
5.11 IMPACT OF US TARIFF—PROTEOMICS MARKET 117
5.11.1 INTRODUCTION 117
5.11.2 KEY TARIFF RATES 117
5.11.3 PRICE IMPACT ANALYSIS 118
5.11.4 IMPACT ON COUNTRIES/REGIONS 119
5.11.4.1 US 119
5.11.4.2 Europe 119
5.11.4.3 Asia Pacific 120
5.11.5 IMPACT ON END-USE INDUSTRIES 120
5.11.5.1 Hospitals 120
5.11.5.2 Clinical laboratories 120
5.11.5.3 Biopharmaceutical companies 121
5.11.5.4 Academic & research institutes 121
6 SUSTAINABILITY AND REGULATORY LANDSCAPE 122
6.1 REGIONAL REGULATIONS AND COMPLIANCE 122
6.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 122
6.1.2 INDUSTRY STANDARDS 125
6.1.2.1 North America 125
6.1.2.2 Europe 125
6.1.2.3 Asia Pacific 126
6.1.2.4 Rest of the world 126
6.2 SUSTAINABILITY INITIATIVES 126
6.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 127
6.4 CERTIFICATIONS, LABELING, ECO-STANDARDS 127
7 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 129
7.1 KEY TECHNOLOGIES 129
7.1.1 MASS SPECTROMETRY 129
7.1.1.1 Intact/top-down protein analysis 129
7.1.1.2 Chromatography 130
7.1.1.3 Bioinformatics tools 130
7.1.1.4 Protein microarrays 130

7.2 COMPLEMENTARY TECHNOLOGIES 131
7.2.1 TRANSCRIPTOMICS 131
7.2.2 METABOLOMICS 131
7.2.3 SINGLE-CELL PROTEOMICS 131
7.3 ADJACENT TECHNOLOGIES 132
7.3.1 AI-DRIVEN PROTEOMICS DATA ANALYSIS 132
7.3.2 AI-DRIVEN PROTEIN STRUCTURE & FUNCTION PREDICTION 132
7.4 TECHNOLOGY ROADMAP 132
7.5 PATENT ANALYSIS 133
7.5.1 METHODOLOGY 133
7.5.2 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE 133
7.5.3 LIST OF KEY PATENTS 134
7.6 FUTURE APPLICATIONS 135
7.7 IMPACT OF AI/GEN AI ON PROTEOMICS MARKET 136
7.7.1 TOP USE CASES AND MARKET POTENTIAL 137
7.7.2 BEST PRACTICES IN AI-ENABLED PROTEOMICS WORKFLOWS 137
7.7.3 CASE STUDIES OF AI IMPLEMENTATION IN PROTEOMICS MARKET 137
7.7.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 138
7.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PROTEOMICS MARKET 138
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 140
8.1 DECISION-MAKING PROCESS 140
8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 140
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 140
8.2.2 KEY BUYING CRITERIA, BY END USER 141
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 142
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 143
9 PROTEOMICS MARKET, BY OFFERING 144
9.1 INTRODUCTION 145
9.2 INSTRUMENTS 145
9.2.1 HIGH-SENSITIVITY AND AUTOMATED PROTEOMICS INSTRUMENT TO DRIVE MARKET GROWTH 145
9.3 REAGENTS & CONSUMABLES 149
9.3.1 SCALABLE MULTIPLEX ASSAYS AND WORKFLOW-READY CONSUMABLES TO DRIVE MARKET 149
9.4 SOFTWARE 152
9.4.1 AI-ENABLED CLOUD-CONNECTED SOFTWARE TO DRIVE MARKET GROWTH 152
9.5 SERVICES 156
9.5.1 OUTSOURCED EXPERTISE AND SCALABLE LC-MS/MS CAPACITY TO DRIVE MARKET 156

10 PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES 160
10.1 INTRODUCTION 161
10.2 IMMUNOASSAY REAGENTS & CONSUMABLES 161
10.2.1 ANTIBODIES & HIGH-AFFINITY BINDERS 165
10.2.1.1 Validated high-affinity binders to aid market growth 165
10.2.2 ASSAY KITS 169
10.2.2.1 Prevalidated assay kits to accelerate market growth 169
10.2.3 OTHER IMMUNOASSAY REAGENTS & CONSUMABLES 172
10.3 SPECTROSCOPY REAGENTS & CONSUMABLES 176
10.3.1 MASS TAGGING & LABELING KITS 180
10.3.1.1 Multiplexed protein quantification to aid market growth 180
10.3.2 ENZYMES 183
10.3.2.1 Automation-ready digestion enzymes to drive market growth 183
10.3.3 OTHER SPECTROSCOPY REAGENTS & CONSUMABLES 186
10.4 CHROMATOGRAPHY REAGENTS & CONSUMABLES 189
10.4.1 ANALYTICAL COLUMNS 193
10.4.1.1 High-sensitivity microflow and bio-inert columns to support market growth 193
10.4.2 REAGENTS 196
10.4.2.1 High-purity and method-compatible solvents to support market growth 196
10.4.3 OTHER CHROMATOGRAPHY REAGENTS & CONSUMABLES 199
10.5 PROTEIN MICROARRAY REAGENTS & CONSUMABLES 202
10.5.1 BIOCHIPS 206
10.5.1.1 Miniaturized, functionalized biochips to drive market growth 206
10.5.1.2 Lab-on-chips 210
10.5.1.2.1 Integrated microfluidic chips to propel market growth 210
10.5.1.3 Protein chips 213
10.5.1.3.1 Functional protein chips are converting biomarker and interaction discovery into scalable multiplex assays to aid market growth 213
10.5.2 DETECTION REAGENTS 217
10.5.2.1 Brighter, lower-background detection chemistries to propel market growth 217
10.6 X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES 220
10.6.1 CRYSTALLIZATION SCREENS 224
10.6.1.1 Automated high-throughput screening to drive market growth 224
10.6.2 OTHER X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES 228
10.7 ELECTROPHORESIS REAGENTS & CONSUMABLES 231
10.7.1 ELECTROPHORESIS STAINS & DYES 235
10.7.1.1 High-sensitivity and MS-compatible stains to improve protein visualization 235
10.7.2 OTHER ELECTROPHORESIS REAGENTS & CONSUMABLES 238
10.8 PROTEIN FRACTIONATION REAGENTS & CONSUMABLES 242
10.8.1 PROTEIN FRACTIONATION & ENRICHMENT KITS 245
10.8.1.1 Automated enrichment kits to drive market growth 245
10.8.2 OTHER PROTEIN FRACTIONATION REAGENTS & CONSUMABLES 249
10.9 OTHER REAGENTS & CONSUMABLES 253
11 PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY 257
11.1 INTRODUCTION 258
11.2 SPECTROSCOPY 258
11.2.1 MASS SPECTROMETRY 262
11.2.1.1 High specificity and technological advancements to propel segment growth 262
11.2.2 NMR SPECTROSCOPY 266
11.2.2.1 Accurate evaluation of physical, chemical, electronic, and structural information of proteins to aid segment growth 266
11.2.3 CD SPECTROSCOPY 270
11.2.3.1 Non-destructive and non-invasive techniques to examine changes in secondary protein structures 270
11.3 CHROMATOGRAPHY 273
11.3.1 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY 277
11.3.1.1 High resolution, sensitivity, and reproducibility to spur segment growth 277
11.3.2 ION CHROMATOGRAPHY 280
11.3.2.1 High resolving power, simplicity, and controllability to separate and purify proteins 280
11.3.3 AFFINITY CHROMATOGRAPHY 284
11.3.3.1 High specificity for target proteins and easy identification of novel protein interactions to drive segment 284
11.3.4 SUPERCRITICAL FLUID CHROMATOGRAPHY 287
11.3.4.1 Ability to separate complex protein mixtures with high efficiency and speed to fuel segment growth 287
11.4 ELECTROPHORESIS 291
11.4.1 GEL ELECTROPHORESIS 295
11.4.1.1 Increasing demand for proteomics research and personalized medicine to boost segment growth 295
11.4.2 CAPILLARY ELECTROPHORESIS 298
11.4.2.1 Low diffusion coefficients of biomolecules and easy elimination of sample carryover between measurements to drive market 298
11.5 PROTEIN MICROARRAYS 302
11.5.1 INTEGRATED SYSTEMS 306
11.5.1.1 Integrated systems to enable high-throughput and reproducible analysis of proteins 306
11.5.2 MICROARRAY SCANNERS 309
11.5.2.1 Cost-effective and high-quality analysis to propel segment growth 309

11.5.3 ARRAYERS 313
11.5.3.1 Technological advancements to drive adoption of arrayers in large-scale projects 313
11.6 X-RAY CRYSTALLOGRAPHY 316
11.6.1 RISING NEED FOR HIGH-RESOLUTION INFORMATION ON PROTEIN STRUCTURES TO AUGMENT MARKET GROWTH 316
11.7 SURFACE PLASMON RESONANCE 319
11.7.1 INCREASING ABILITY TO BIND AFFINITIES AND KINETICS OF COMPLEXES TO PROPEL MARKET GROWTH 319
11.8 PROTEIN FRACTIONATION 323
11.8.1 PROTEIN FRACTIONATION TO ENABLE EFFECTIVE SEPARATION OF PROTEINS IN COMPLEX MIXTURES 323
11.9 OTHER INSTRUMENTATION TECHNOLOGIES 326
12 PROTEOMICS MARKET, BY SERVICE 330
12.1 INTRODUCTION 331
12.2 CORE PROTEOMICS SERVICES 331
12.2.1 PROTEIN IDENTIFICATION SERVICES 335
12.2.1.1 Outsourced mass spectrometry and complex-sample workflows to boost market growth 335
12.2.2 QUANTITATIVE PROTEOMICS SERVICES 339
12.2.2.1 Quantified protein profiling and translational model validation to drive market growth 339
12.2.3 PROTEIN CHARACTERIZATION SERVICES 342
12.2.3.1 Biologics complexity and comparability testing to drive market growth 342
12.2.4 PROTEIN PURIFICATION SERVICES 346
12.2.4.1 High-purity biologics and outsourced purification expertise to drive market 346
12.2.5 PROTEIN SEPARATION SERVICES 349
12.2.5.1 Complex sample analysis and biomarker research to augment segment growth 349
12.2.6 PROTEIN SEQUENCING SERVICES 353
12.2.6.1 Antibody development and outsourced sequence interpretation to drive market 353
12.2.7 CUSTOM ASSAY SERVICES 356
12.2.7.1 Biomarker specificity and outsourced assay design to drive market 356
12.3 BIOINFORMATICS SERVICES 360
12.3.1 SCALABLE DATA INTERPRETATION AND MULTI-OMICS INTEGRATION TO SPUR MARKET GROWTH 360

13 PROTEOMICS MARKET, BY SOFTWARE 364
13.1 INTRODUCTION 365
13.2 BIOINFORMATICS TOOLS 365
13.2.1 RISING DATA COMPLEXITY AND AI-ENABLED ANALYSIS TO AUGMENT MARKET GROWTH 365
13.3 BIOINFORMATICS DATABASES 369
13.3.1 EXPANDING CURATED PROTEIN KNOWLEDGEBASES AND MULTI-OMICS INTEGRATION TO DRIVE MARKET 369
14 PROTEOMICS MARKET, BY WORKFLOW 373
14.1 INTRODUCTION 374
14.2 SAMPLE PREPARATION 374
14.2.1 AUTOMATION, REPRODUCIBILITY, AND HIGH-THROUGHPUT BIOMARKER WORKFLOWS TO AUGMENT MARKET GROWTH 374
14.3 PROTEIN SEPARATION & FRACTIONATION 378
14.3.1 RISING DEMAND FOR DEEPER PROTEOME COVERAGE AND IMPROVED LC-MS SENSITIVITY TO DRIVE MARKET 378
14.4 PROTEIN IDENTIFICATION & QUANTIFICATION 381
14.4.1 HIGHER SENSITIVITY, DEEPER PROTEOME COVERAGE, AND SCALABLE QUANTIFICATION WORKFLOWS TO AUGMENT MARKET GROWTH 381
14.5 PROTEIN CHARACTERIZATION & STRUCTURAL ANALYSIS 385
14.5.1 RISING BIOLOGICS COMPLEXITY AND DEMAND FOR STRUCTURE-FUNCTION INSIGHTS TO DRIVE MARKET 385
14.6 BIOINFORMATICS & DATA ANALYSIS 388
14.6.1 RISING DATA COMPLEXITY, DIA ADOPTION, AND AI-ENABLED INTERPRETATION TO DRIVE MARKET 388
15 PROTEOMICS MARKET, BY TYPE 392
15.1 INTRODUCTION 393
15.1.1 BULK PROTEOMICS 393
15.1.1.1 Large-cohort biomarker discovery, high-throughput protein profiling, and scalable multi-omics integration to drive market growth 393
15.1.2 TARGETED/AFFINITY PROTEOMICS 397
15.1.2.1 High-sensitivity protein panels and scalable biomarker validation to drive the market 397
15.1.3 SPATIAL PROTEOMICS 400
15.1.3.1 Emerging spatial biology workflows to drive market growth 400
15.1.4 SINGLE MOLECULE PROTEOMICS/NEXT GENERATION PROTEOMICS 404
15.1.4.1 Demand for ultra-sensitive and low-input protein analysis to drive market 404

16 PROTEOMICS MARKET, BY APPLICATION 408
16.1 INTRODUCTION 409
16.2 CLINICAL DIAGNOSTICS 409
16.2.1 CANCER 413
16.2.1.1 Precision oncology and high-sensitivity protein biomarker testing to propel market growth 413
16.2.2 INFECTIOUS DISEASES 417
16.2.2.1 Rapid pathogen identification to support market growth 417
16.2.3 DIABETES 420
16.2.3.1 Precision diabetes care and protein-based risk stratification to aid market growth 420
16.2.4 NEUROLOGICAL DISORDERS 424
16.2.4.1 Blood-based neuroprotein biomarkers to fuel market growth 424
16.2.5 AUTOIMMUNE DISEASES 427
16.2.5.1 Demand for immune-pathway biomarkers and flare monitoring to propel market growth 427
16.2.6 CARDIOVASCULAR DISEASES 431
16.2.6.1 Multi-protein cardiovascular risk profiling to drive growth 431
16.2.7 OTHER CLINICAL DIAGNOSTIC APPLICATIONS 434
16.3 DRUG DISCOVERY & DEVELOPMENT 438
16.3.1 TARGET DISCOVERY 442
16.3.1.1 High-throughput proteomics and AI-enabled target biology to support segment growth 442
16.3.2 LEAD IDENTIFICATION 445
16.3.2.1 Chemoproteomics and high-throughput protein profiling to propel growth 445
16.3.3 LEAD OPTIMIZATION 449
16.3.3.1 Need for optimizing drug efficacy and safety to spur segment growth 449
16.3.4 PRECLINICAL STUDIES 452
16.3.4.1 Translational safety biomarkers and pathway-level efficacy assessment to drive growth 452
16.4 OTHER APPLICATIONS 456
17 PROTEOMICS MARKET, BY END USER 460
17.1 INTRODUCTION 461
17.2 BIOPHARMACEUTICAL COMPANIES 461
17.2.1 PRECISION MEDICINE, BIOMARKER-LED R&D, AND POPULATION-SCALE PROTEOMICS TO DRIVE MARKET 461
17.3 ACADEMIC & RESEARCH INSTITUTES 465
17.3.1 SHARED CORE INFRASTRUCTURE AND MULTI-OMICS RESEARCH MEDICINE TO BOOST MARKET GROWTH 465
17.4 HOSPITALS 468
17.4.1 PRECISION DIAGNOSTICS AND HOSPITAL-BASED TRANSLATIONAL RESEARCH TO BOOST MARKET GROWTH 468
17.5 CLINICAL LABORATORIES 472
17.5.1 PROTEIN-BASED DIAGNOSTICS AND LABORATORY WORKFLOW AUTOMATION TO SUPPORT MARKET GROWTH 472
17.6 OTHER END USERS 475
18 PROTEOMICS MARKET, BY REGION 479
18.1 INTRODUCTION 480
18.2 NORTH AMERICA 480
18.2.1 US 492
18.2.1.1 Precision medicine, high-throughput platforms, and biomarker-driven drug development to drive the market growth. 492
18.2.2 CANADA 503
18.2.2.1 Precision oncology networks, standardized LC-MS workflows, and AI-enabled multiomics to drive the market growth 503
18.3 EUROPE 514
18.3.1 GERMANY 525
18.3.1.1 Well-established pharmaceutical industry and increased government funding to augment market growth 525
18.3.2 UK 536
18.3.2.1 Population biobanks, clinical cohorts, and high-throughput multiomics to drive market growth 536
18.3.3 FRANCE 547
18.3.3.1 National infrastructure, clinical biomarker programs, and multiomics collaboration to drive the market growth 547
18.3.4 SWITZERLAND 558
18.3.4.1 Pharma-led innovation, deep plasma proteomics, and translational multiomics to drive the market growth 558
18.3.5 ITALY 569
18.3.5.1 Clinical multiomics, biomarker research, and cross-border proteomics collaboration to drive the market growth 569
18.3.6 SPAIN 580
18.3.6.1 Spatial omics infrastructure, clinical collaboration, and high-throughput proteomics to drive the market growth 580
18.3.7 REST OF EUROPE 591
18.4 ASIA PACIFIC 602
18.4.1 CHINA 614
18.4.1.1 Precision medicine investment, automated LC-MS/MS workflows, and large-scale clinical proteomics to fuel market growth 614
18.4.2 JAPAN 625
18.4.2.1 Precision medicine, automated LC-MS/MS workflows, and clinical biomarker programs to drive market 625
18.4.3 INDIA 636
18.4.3.1 Biopharma R&D and LC-MS/MS adoption to support market growth 636
18.4.4 SOUTH KOREA 647
18.4.4.1 Biopharma innovation, high-plex protein profiling, and automated multiomics workflows to propel market growth 647
18.4.5 AUSTRALIA 658
18.4.5.1 Translational biomedicine, high-resolution LC-MS/MS, and automated protein analytics to favor market growth 658
18.4.6 REST OF ASIA PACIFIC 669
18.5 LATIN AMERICA 679
18.5.1 BRAZIL 690
18.5.1.1 Open LC-MS/MS infrastructure and translational biomarker programs to drive market 690
18.5.2 MEXICO 701
18.5.2.1 Oncology biomarker research to augment market growth 701
18.5.3 REST OF LATIN AMERICA 712
18.6 MIDDLE EAST 723
18.6.1 GCC COUNTRIES 734
18.6.1.1 Saudi Arabia 745
18.6.1.1.1 Biotechnology localization and clinical biomarker research to boost market growth 745
18.6.1.2 UAE 756
18.6.1.2.1 Multiomics infrastructure and public-private research partnerships to drive market 756
18.6.1.3 Rest of GCC Countries 767
18.6.2 REST OF MIDDLE EAST 778
18.7 AFRICA 789
18.7.1 BIOMARKER PLATFORM ADOPTION TO PROPEL MARKET GROWTH 789
19 COMPETITIVE LANDSCAPE 801
19.1 INTRODUCTION 801
19.2 KEY PLAYER STRATEGY/RIGHT TO WIN, 2021–2025 801
19.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PROTEOMICS MARKET, JANUARY 2023-APRIL 2026 801
19.3 REVENUE ANALYSIS, 2021–2025 803
19.4 MARKET SHARE ANALYSIS, 2025 804
19.5 BRAND COMPARISON 807
19.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 808
19.6.1 STARS 808
19.6.2 EMERGING LEADERS 808
19.6.3 PERVASIVE PLAYERS 808
19.6.4 PARTICIPANTS 808
19.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 810
19.6.5.1 Company footprint 810
19.6.5.2 Region footprint 811
19.6.5.3 Instrumentation technology footprint 812
19.6.5.4 Reagent footprint 813
19.6.5.5 Service footprint 815
19.6.5.6 Software footprint 816
19.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 817
19.7.1 PROGRESSIVE COMPANIES 817
19.7.2 RESPONSIVE COMPANIES 817
19.7.3 DYNAMIC COMPANIES 817
19.7.4 STARTING BLOCKS 817
19.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 819
19.7.5.1 Detailed list of key startup/SME players 819
19.7.5.2 Competitive benchmarking of startups/SMEs 820
19.8 COMPANY VALUATION AND FINANCIAL METRICS 821
19.8.1 COMPANY VALUATION 821
19.8.2 FINANCIAL METRICS 822
19.9 COMPETITIVE SCENARIO 822
19.9.1 PRODUCT LAUNCHES 822
19.9.2 DEALS 823
19.9.3 EXPANSIONS 824
20 COMPANY PROFILES 825
20.1 KEY PLAYERS 825
20.1.1 THERMO FISHER SCIENTIFIC INC. 825
20.1.1.1 Business overview 825
20.1.1.2 Products/Services/Solutions offered 826
20.1.1.3 Recent developments 839
20.1.1.3.1 Product launches 839
20.1.1.3.2 Deals 840
20.1.1.4 MnM view 840
20.1.1.4.1 Key strengths 840
20.1.1.4.2 Strategic choices 840
20.1.1.4.3 Weaknesses and competitive threats 840
20.1.2 AGILENT TECHNOLOGIES, INC. 841
20.1.2.1 Business overview 841
20.1.2.2 Products/Services/Solutions offered 842
20.1.2.3 Recent developments 847
20.1.2.3.1 Product launches 847
20.1.2.3.2 Deals 848
20.1.2.3.3 Expansions 849
20.1.2.4 MnM view 849
20.1.2.4.1 Key strengths 849
20.1.2.4.2 Strategic choices 849
20.1.2.4.3 Weaknesses and competitive threats 849

20.1.3 MERCK KGAA 850
20.1.3.1 Business overview 850
20.1.3.2 Products/Services/Solutions offered 851
20.1.3.3 Recent developments 854
20.1.3.3.1 Deals 854
20.1.3.4 MnM view 854
20.1.3.4.1 Key strengths 854
20.1.3.4.2 Strategic choices 854
20.1.3.4.3 Weaknesses and competitive threats 854
20.1.4 DANAHER CORPORATION 855
20.1.4.1 Business overview 855
20.1.4.2 Products/Services/Solutions offered 856
20.1.4.3 Recent developments 868
20.1.4.3.1 Product launches 868
20.1.4.3.2 Deals 869
20.1.4.4 MnM view 869
20.1.4.4.1 Key strengths 869
20.1.4.4.2 Strategic choices 869
20.1.4.4.3 Weaknesses and competitive threats 869
20.1.5 SHIMADZU CORPORATION 870
20.1.5.1 Business overview 870
20.1.5.2 Products/Services/Solutions offered 871
20.1.5.3 Recent developments 876
20.1.5.3.1 Product launches 876
20.1.5.3.2 Expansions 876
20.1.5.4 MnM view 877
20.1.5.4.1 Key strengths 877
20.1.5.4.2 Strategic choices 877
20.1.5.4.3 Weaknesses and competitive threats 877
20.1.6 WATERS CORPORATION 878
20.1.6.1 Business overview 878
20.1.6.2 Products/Services/Solutions offered 879
20.1.6.3 Recent developments 886
20.1.6.3.1 Product launches 886
20.1.6.3.2 Deals 886
20.1.7 BIO-RAD LABORATORIES, INC. 887
20.1.7.1 Business overview 887
20.1.7.2 Products/Services/Solutions offered 888

20.1.8 BRUKER 897
20.1.8.1 Business overview 897
20.1.8.2 Products/Services/Solutions offered 898
20.1.8.3 Recent developments 904
20.1.8.3.1 Product launches 904
20.1.8.3.2 Deals 905
20.1.9 REVVITY 906
20.1.9.1 Business overview 906
20.1.9.2 Products/Services/Solutions offered 907
20.1.9.3 Recent developments 910
20.1.9.3.1 Product launches 910
20.1.10 ILLUMINA, INC. 911
20.1.10.1 Business overview 911
20.1.10.2 Products/Services/Solutions offered 912
20.1.10.3 Recent developments 914
20.1.10.3.1 Deals 914
20.1.11 PROMEGA CORPORATION 915
20.1.11.1 Business overview 915
20.1.11.2 Products/Services/Solutions offered 915
20.1.12 EUROFINS SCIENTIFIC 919
20.1.12.1 Business overview 919
20.1.12.2 Products/Services/Solutions offered 920
20.1.12.3 Recent developments 921
20.1.12.3.1 Deals 921
20.1.13 QIAGEN 922
20.1.13.1 Business overview 922
20.1.13.2 Products/Services/Solutions offered 923
20.1.13.3 Recent developments 926
20.1.13.3.1 Product launches 926
20.1.13.3.2 Deals 927
20.1.14 CHARLES RIVER LABORATORIES 928
20.1.14.1 Business overview 928
20.1.14.2 Products/Services/Solutions offered 929
20.1.14.3 Recent developments 931
20.1.14.3.1 Product launches 931
20.1.14.3.2 Deals 932
20.1.15 PROTAGENE 933
20.1.15.1 Business overview 933
20.1.15.2 Products/Services/Solutions offered 933
20.1.16 BIO-TECHNE 936
20.1.16.1 Business overview 936
20.1.16.2 Products/Services/Solutions offered 937
20.1.17 AZENTA US INC. 939
20.1.17.1 Business overview 939
20.1.17.2 Products/Services/Solutions offered 940
20.1.18 QUANTERIX 941
20.1.18.1 Business overview 941
20.1.18.2 Products/Services/Solutions offered 942
20.1.19 PROTEOMICS INTERNATIONAL 943
20.1.19.1 Business overview 943
20.1.19.2 Products/Services/Solutions offered 944
20.1.20 HAMILTON COMPANY 945
20.1.20.1 Business overview 945
20.1.20.2 Products/Services/Solutions offered 945
20.1.20.3 Recent developments 946
20.1.20.3.1 Product launches 946
20.2 OTHER PLAYERS 947
20.2.1 CREATIVE PROTEOMICS 947
20.2.2 HORIBA, LTD. 949
20.2.3 LABVANTAGE-BIOMAX GMBH 950
20.2.4 FIOS GENOMICS 951
20.2.5 MEDGENOME 952
20.2.6 BIOGNOSYS AG 953
20.2.7 MACROGEN, INC. 954
20.2.8 CELL SIGNALING TECHNOLOGY, INC. 955
20.2.9 STANDARD BIOTOOLS 956
20.2.10 PIXELGEN TECHNOLOGIES 957
20.2.11 APPLIED BIOMICS 957
20.2.12 QUANTUM-SI INCORPORATED 958
20.2.13 ERISYON INC. 959
20.2.14 NAUTILUS BIOTECHNOLOGY, INC. 960
21 RESEARCH METHODOLOGY 961
21.1 RESEARCH DATA 961
21.1.1 SECONDARY DATA 961
21.1.1.1 Key data from secondary sources 961
21.1.2 PRIMARY DATA 962
21.1.2.1 Key data from primary sources 962
21.1.2.2 Key primary participants 963
21.1.2.3 Breakdown of primary interviews 963
21.1.2.4 Key industry insights 964
21.2 MARKET SIZE ESTIMATION 965
21.2.1 GLOBAL PROTEOMICS MARKET ESTIMATION, 2025 965
21.2.2 SEGMENTAL MARKET SIZE ESTIMATION 967
21.3 MARKET GROWTH RATE PROJECTIONS 969
21.4 DATA TRIANGULATION 971
21.5 FACTOR ANALYSIS 972
21.6 RESEARCH ASSUMPTIONS 972
21.7 RESEARCH LIMITATIONS AND RISK ASSESSMENT 973
22 APPENDIX 974
22.1 DISCUSSION GUIDE 974
22.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 979
22.3 CUSTOMIZATION OPTIONS 981
22.4 RELATED REPORTS 981
22.5 AUTHOR DETAILS 982

LIST OF TABLES

TABLE 1 PROTEOMICS MARKET: INCLUSIONS AND EXCLUSIONS 80
TABLE 2 PROTEOMICS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 92
TABLE 3 PROTEOMICS MARKET: PORTER’S FIVE FORCES 100
TABLE 4 PROTEOMICS MARKET: ROLE OF PLAYERS IN ECOSYSTEM 106
TABLE 5 AVERAGE SELLING PRICE TREND OF INSTRUMENTATION, BY KEY PLAYER,
2023–2025 (USD) 108
TABLE 6 AVERAGE SELLING PRICE TREND OF REAGENTS, BY KEY PLAYER,
2023-2025 (USD) 109
TABLE 7 AVERAGE SELLING PRICE TREND OF INSTRUMENTATION, BY REGION,
2023–2025 (USD) 109
TABLE 8 AVERAGE SELLING PRICE TREND OF REAGENTS, BY REGION, 2023–2025 (USD) 110
TABLE 9 IMPORT DATA FOR HS CODE 9027.20-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 111
TABLE 10 EXPORT DATA FOR HS CODE 9027.20-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 112
TABLE 11 IMPORT DATA FOR HS CODE 9027.81-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 112
TABLE 12 EXPORT DATA FOR HS CODE 9027.81-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 113
TABLE 13 PROTEOMICS MARKET: LIST OF KEY CONFERENCES & EVENTS,
JANUARY 2026–MARCH 2027 114
TABLE 14 RECIPROCAL TARIFF RATES ADJUSTED BY US 117
TABLE 15 CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES 119
TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 122
TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 123
TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 124
TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 124
TABLE 20 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2015–2025 133
TABLE 21 LIST OF KEY PATENTS IN THE PROTEOMICS MARKET, 2023-2025 134
TABLE 22 CASE STUDIES OF AI IMPLEMENTATION IN PROTEOMICS MARKET 137
TABLE 23 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PROTEOMICS MARKET 138
TABLE 24 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 141
TABLE 25 KEY BUYING CRITERIA, BY END USER 141
TABLE 26 PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 145
TABLE 27 PROTEOMICS INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 146
TABLE 28 NORTH AMERICA: PROTEOMICS INSTRUMENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 146
TABLE 29 EUROPE: PROTEOMICS INSTRUMENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 147
TABLE 30 ASIA PACIFIC: PROTEOMICS INSTRUMENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 147
TABLE 31 LATIN AMERICA: PROTEOMICS INSTRUMENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 148
TABLE 32 MIDDLE EAST: PROTEOMICS INSTRUMENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 148
TABLE 33 GCC COUNTRIES: PROTEOMICS INSTRUMENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 148
TABLE 34 PROTEOMICS REAGENTS & CONSUMABLES MARKET, BY REGION,
2024–2031 (USD MILLION) 149
TABLE 35 NORTH AMERICA: PROTEOMICS REAGENTS & CONSUMABLES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 150
TABLE 36 EUROPE: PROTEOMICS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 150
TABLE 37 ASIA PACIFIC: PROTEOMICS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 151
TABLE 38 LATIN AMERICA: PROTEOMICS REAGENTS & CONSUMABLES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 151
TABLE 39 MIDDLE EAST: PROTEOMICS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 152
TABLE 40 GCC COUNTRIES: PROTEOMICS REAGENTS & CONSUMABLES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 152
TABLE 41 PROTEOMICS SOFTWARE MARKET, BY REGION, 2024–2031 (USD MILLION) 153
TABLE 42 NORTH AMERICA: PROTEOMICS SOFTWARE MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 153
TABLE 43 EUROPE: PROTEOMICS SOFTWARE MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 154
TABLE 44 ASIA PACIFIC: PROTEOMICS SOFTWARE MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 154
TABLE 45 LATIN AMERICA: PROTEOMICS SOFTWARE MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 155
TABLE 46 MIDDLE EAST: PROTEOMICS SOFTWARE MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 155
TABLE 47 GCC COUNTRIES: PROTEOMICS SOFTWARE MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 155
TABLE 48 PROTEOMICS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 156
TABLE 49 NORTH AMERICA: PROTEOMICS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 157
TABLE 50 EUROPE: PROTEOMICS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 157
TABLE 51 ASIA PACIFIC: PROTEOMICS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 158
TABLE 52 LATIN AMERICA: PROTEOMICS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 158
TABLE 53 MIDDLE EAST: PROTEOMICS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 158
TABLE 54 GCC COUNTRIES: PROTEOMICS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 159
TABLE 55 PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024–2031 (USD MILLION) 161
TABLE 56 PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES,
BY TYPE, 2024–2031 (USD MILLION) 162
TABLE 57 PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES,
BY REGION, 2024–2031 (USD MILLION) 162
TABLE 58 NORTH AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 163
TABLE 59 EUROPE: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 163
TABLE 60 ASIA PACIFIC: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 164
TABLE 61 LATIN AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 164
TABLE 62 MIDDLE EAST: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 165
TABLE 63 GCC COUNTRIES: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 165
TABLE 64 IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ANTIBODIES & HIGH-AFFINITY BINDERS, BY REGION, 2024–2031 (USD MILLION) 166
TABLE 65 NORTH AMERICA: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ANTIBODIES & HIGH-AFFINITY BINDERS, BY COUNTRY, 2024–2031 (USD MILLION) 166
TABLE 66 EUROPE: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ANTIBODIES & HIGH-AFFINITY BINDERS, BY COUNTRY, 2024–2031 (USD MILLION) 167
TABLE 67 ASIA PACIFIC: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ANTIBODIES & HIGH-AFFINITY BINDERS, BY COUNTRY, 2024–2031 (USD MILLION) 167
TABLE 68 LATIN AMERICA: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ANTIBODIES & HIGH-AFFINITY BINDERS, BY COUNTRY, 2024–2031 (USD MILLION) 168
TABLE 69 MIDDLE EAST: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ANTIBODIES & HIGH-AFFINITY BINDERS, BY COUNTRY, 2024–2031 (USD MILLION) 168
TABLE 70 GCC COUNTRIES: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ANTIBODIES & HIGH-AFFINITY BINDERS, BY COUNTRY, 2024–2031 (USD MILLION) 168
TABLE 71 IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ASSAY KITS, BY REGION, 2024–2031 (USD MILLION) 169
TABLE 72 NORTH AMERICA: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2024–2031 (USD MILLION) 170
TABLE 73 EUROPE: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2024–2031 (USD MILLION) 170
TABLE 74 ASIA PACIFIC: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2024–2031 (USD MILLION) 171
TABLE 75 LATIN AMERICA: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2024–2031 (USD MILLION) 171
TABLE 76 MIDDLE EAST: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2024–2031 (USD MILLION) 171
TABLE 77 GCC COUNTRIES: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2024–2031 (USD MILLION) 172
TABLE 78 IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR OTHER IMMUNOASSAY REAGENTS & CONSUMABLES, BY REGION, 2024–2031 (USD MILLION) 173
TABLE 79 NORTH AMERICA: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR OTHER IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY,
2024–2031 (USD MILLION) 173
TABLE 80 EUROPE: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR OTHER IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY,
2024–2031 (USD MILLION) 174
TABLE 81 ASIA PACIFIC: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR OTHER IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY,
2024–2031 (USD MILLION) 174
TABLE 82 LATIN AMERICA: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR OTHER IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY,
2024–2031 (USD MILLION) 175
TABLE 83 MIDDLE EAST: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR OTHER IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY,
2024–2031 (USD MILLION) 175
TABLE 84 GCC COUNTRIES: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR OTHER IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY,
2024–2031 (USD MILLION) 175
TABLE 85 PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES,
BY TYPE, 2024–2031 (USD MILLION) 176
TABLE 86 PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES,
BY REGION, 2024–2031 (USD MILLION) 177
TABLE 87 NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 177
TABLE 88 EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 178
TABLE 89 ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 178
TABLE 90 LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 179
TABLE 91 MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 179
TABLE 92 GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 179
TABLE 93 SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR MASS TAGGING & LABELING KITS, BY REGION, 2024–2031 (USD MILLION) 180
TABLE 94 NORTH AMERICA: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR MASS TAGGING & LABELING KITS, BY COUNTRY, 2024–2031 (USD MILLION) 180
TABLE 95 EUROPE: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR MASS TAGGING & LABELING KITS, BY COUNTRY, 2024–2031 (USD MILLION) 181
TABLE 96 ASIA PACIFIC: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR MASS TAGGING & LABELING KITS, BY COUNTRY, 2024–2031 (USD MILLION) 181
TABLE 97 LATIN AMERICA: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR MASS TAGGING & LABELING KITS, BY COUNTRY, 2024–2031 (USD MILLION) 182
TABLE 98 MIDDLE EAST: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR MASS TAGGING & LABELING KITS, BY COUNTRY, 2024–2031 (USD MILLION) 182
TABLE 99 GCC COUNTRIES: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR MASS TAGGING & LABELING KITS, BY COUNTRY, 2024–2031 (USD MILLION) 182
TABLE 100 SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR ENZYMES, BY REGION, 2024–2031 (USD MILLION) 183
TABLE 101 NORTH AMERICA: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR ENZYMES, BY COUNTRY, 2024–2031 (USD MILLION) 183
TABLE 102 EUROPE: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR ENZYMES, BY COUNTRY, 2024–2031 (USD MILLION) 184
TABLE 103 ASIA PACIFIC: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR ENZYMES, BY COUNTRY, 2024–2031 (USD MILLION) 184
TABLE 104 LATIN AMERICA: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR ENZYMES, BY COUNTRY, 2024–2031 (USD MILLION) 185
TABLE 105 MIDDLE EAST: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR ENZYMES, BY COUNTRY, 2024–2031 (USD MILLION) 185
TABLE 106 GCC COUNTRIES: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR ENZYMES, BY COUNTRY, 2024–2031 (USD MILLION) 185
TABLE 107 OTHER SPECTROSCOPY REAGENTS & CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 186
TABLE 108 NORTH AMERICA: OTHER SPECTROSCOPY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 186
TABLE 109 EUROPE: OTHER SPECTROSCOPY REAGENTS & CONSUMABLES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 187
TABLE 110 ASIA PACIFIC: OTHER SPECTROSCOPY REAGENTS & CONSUMABLES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 187
TABLE 111 LATIN AMERICA: OTHER SPECTROSCOPY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 188
TABLE 112 MIDDLE EAST: OTHER SPECTROSCOPY REAGENTS & CONSUMABLES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 188
TABLE 113 GCC COUNTRIES: OTHER SPECTROSCOPY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 188
TABLE 114 PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES,
BY TYPE, 2024–2031 (USD MILLION) 189
TABLE 115 PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES,
BY REGION, 2024–2031 (USD MILLION) 190
TABLE 116 NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 190
TABLE 117 EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 191
TABLE 118 ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 191
TABLE 119 LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 192
TABLE 120 MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 192
TABLE 121 GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 192
TABLE 122 CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR ANALYTICAL COLUMNS, BY REGION, 2024–2031 (USD MILLION) 193
TABLE 123 NORTH AMERICA: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR ANALYTICAL COLUMNS, BY COUNTRY, 2024–2031 (USD MILLION) 193
TABLE 124 EUROPE: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR ANALYTICAL COLUMNS, BY COUNTRY, 2024–2031 (USD MILLION) 194
TABLE 125 ASIA PACIFIC: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR ANALYTICAL COLUMNS, BY COUNTRY, 2024–2031 (USD MILLION) 194
TABLE 126 LATIN AMERICA: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR ANALYTICAL COLUMNS, BY COUNTRY, 2024–2031 (USD MILLION) 195
TABLE 127 MIDDLE EAST: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR ANALYTICAL COLUMNS, BY COUNTRY, 2024–2031 (USD MILLION) 195
TABLE 128 GCC COUNTRIES: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR ANALYTICAL COLUMNS, BY COUNTRY, 2024–2031 (USD MILLION) 195
TABLE 129 CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR REAGENTS, BY REGION, 2024–2031 (USD MILLION) 196
TABLE 130 NORTH AMERICA: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 196
TABLE 131 EUROPE: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 197
TABLE 132 ASIA PACIFIC: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 197
TABLE 133 LATIN AMERICA: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 198
TABLE 134 MIDDLE EAST: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 198
TABLE 135 GCC COUNTRIES: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 198
TABLE 136 OTHER CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 199
TABLE 137 NORTH AMERICA: OTHER CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 199
TABLE 138 EUROPE: OTHER CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 200
TABLE 139 ASIA PACIFIC: OTHER CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 200
TABLE 140 LATIN AMERICA: OTHER CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 201
TABLE 141 MIDDLE EAST: OTHER CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 201
TABLE 142 GCC COUNTRIES: OTHER CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 201
TABLE 143 PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 202
TABLE 144 PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY REGION, 2024–2031 (USD MILLION) 203
TABLE 145 PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 203
TABLE 146 EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 204
TABLE 147 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 204
TABLE 148 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 205
TABLE 149 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 205
TABLE 150 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 205
TABLE 151 PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 206
TABLE 152 PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR BIOCHIPS, BY REGION, 2024–2031 (USD MILLION) 207
TABLE 153 NORTH AMERICA: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR BIOCHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 207
TABLE 154 EUROPE: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR BIOCHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 208
TABLE 155 ASIA PACIFIC: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR BIOCHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 208
TABLE 156 LATIN AMERICA: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR BIOCHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 209
TABLE 157 MIDDLE EAST: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR BIOCHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 209
TABLE 158 GCC COUNTRIES: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR BIOCHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 209
TABLE 159 PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR LAB-ON-CHIPS, BY REGION, 2024–2031 (USD MILLION) 210
TABLE 160 NORTH AMERICA: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR LAB-ON-CHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 211
TABLE 161 EUROPE: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR LAB-ON-CHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 211
TABLE 162 ASIA PACIFIC: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR LAB-ON-CHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 212
TABLE 163 LATIN AMERICA: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR LAB-ON-CHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 212
TABLE 164 MIDDLE EAST: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR LAB-ON-CHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 213
TABLE 165 GCC COUNTRIES: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR LAB-ON-CHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 213
TABLE 166 PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR PROTEIN CHIPS, BY REGION, 2024–2031 (USD MILLION) 214
TABLE 167 NORTH AMERICA: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR PROTEIN CHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 214
TABLE 168 EUROPE: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR PROTEIN CHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 215
TABLE 169 ASIA PACIFIC: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR PROTEIN CHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 215
TABLE 170 LATIN AMERICA: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR PROTEIN CHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 216
TABLE 171 MIDDLE EAST: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR PROTEIN CHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 216
TABLE 172 GCC COUNTRIES: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR PROTEIN CHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 216
TABLE 173 PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR DETECTION REAGENTS, BY REGION, 2024–2031 (USD MILLION) 217
TABLE 174 NORTH AMERICA: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR DETECTION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 218
TABLE 175 EUROPE: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR DETECTION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 218
TABLE 176 ASIA PACIFIC: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR DETECTION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 219
TABLE 177 LATIN AMERICA: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR DETECTION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 219
TABLE 178 MIDDLE EAST: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR DETECTION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 220
TABLE 179 GCC COUNTRIES: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR DETECTION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 220
TABLE 180 PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 221
TABLE 181 PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY REGION, 2024–2031 (USD MILLION) 221
TABLE 182 NORTH AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 222
TABLE 183 EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 222
TABLE 184 ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 223
TABLE 185 LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 223
TABLE 186 MIDDLE EAST: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 223
TABLE 187 GCC COUNTRIES: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 224
TABLE 188 X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET FOR CRYSTALLIZATION SCREENS, BY REGION, 2024–2031 (USD MILLION) 225
TABLE 189 NORTH AMERICA: X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET FOR CRYSTALLIZATION SCREENS, BY COUNTRY,
2024–2031 (USD MILLION) 225
TABLE 190 EUROPE: X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET FOR CRYSTALLIZATION SCREENS, BY COUNTRY, 2024–2031 (USD MILLION) 226
TABLE 191 ASIA PACIFIC: X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET FOR CRYSTALLIZATION SCREENS, BY COUNTRY, 2024–2031 (USD MILLION) 226
TABLE 192 LATIN AMERICA: X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET FOR CRYSTALLIZATION SCREENS, BY COUNTRY, 2024–2031 (USD MILLION) 227
TABLE 193 MIDDLE EAST: X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET FOR CRYSTALLIZATION SCREENS, BY COUNTRY, 2024–2031 (USD MILLION) 227
TABLE 194 GCC COUNTRIES: X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET FOR CRYSTALLIZATION SCREENS, BY COUNTRY,
2024–2031 (USD MILLION) 227
TABLE 195 OTHER X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET,
BY REGION, 2024–2031 (USD MILLION) 228
TABLE 196 NORTH AMERICA: OTHER X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 228
TABLE 197 EUROPE: OTHER X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 229
TABLE 198 ASIA PACIFIC: OTHER X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 229
TABLE 199 LATIN AMERICA: OTHER X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 230
TABLE 200 MIDDLE EAST: OTHER X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 230
TABLE 201 GCC COUNTRIES: OTHER X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 230
TABLE 202 PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 231
TABLE 203 PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY REGION, 2024–2031 (USD MILLION) 232
TABLE 204 NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 232
TABLE 205 EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 233
TABLE 206 ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 233
TABLE 207 LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 234
TABLE 208 MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 234
TABLE 209 GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 234
TABLE 210 ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET FOR ELECTROPHORESIS STAINS & DYES, BY REGION, 2024–2031 (USD MILLION) 235
TABLE 211 NORTH AMERICA: ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET FOR ELECTROPHORESIS STAINS & DYES, BY COUNTRY, 2024–2031 (USD MILLION) 236
TABLE 212 EUROPE: ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET FOR ELECTROPHORESIS STAINS & DYES, BY COUNTRY, 2024–2031 (USD MILLION) 236
TABLE 213 ASIA PACIFIC: ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET FOR ELECTROPHORESIS STAINS & DYES, BY COUNTRY, 2024–2031 (USD MILLION) 237
TABLE 214 LATIN AMERICA: ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET FOR ELECTROPHORESIS STAINS & DYES, BY COUNTRY, 2024–2031 (USD MILLION) 237
TABLE 215 MIDDLE EAST: ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET FOR ELECTROPHORESIS STAINS & DYES, BY COUNTRY, 2024–2031 (USD MILLION) 238
TABLE 216 GCC COUNTRIES: ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET FOR ELECTROPHORESIS STAINS & DYES, BY COUNTRY, 2024–2031 (USD MILLION) 238
TABLE 217 OTHER ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 239
TABLE 218 NORTH AMERICA: OTHER ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 239
TABLE 219 EUROPE: OTHER ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 240
TABLE 220 ASIA PACIFIC: OTHER ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 240
TABLE 221 LATIN AMERICA: OTHER ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 241
TABLE 222 MIDDLE EAST: OTHER ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 241
TABLE 223 GCC COUNTRIES: OTHER ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 241
TABLE 224 PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY REGION, 2024–2031 (USD MILLION) 242
TABLE 225 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 243
TABLE 226 EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 243
TABLE 227 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 244
TABLE 228 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 244
TABLE 229 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 245
TABLE 230 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 245
TABLE 231 PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 246
TABLE 232 PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET FOR PROTEIN FRACTIONATION & ENRICHMENT KITS, BY REGION, 2024–2031 (USD MILLION) 246
TABLE 233 NORTH AMERICA: PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET FOR PROTEIN FRACTIONATION & ENRICHMENT KITS, BY COUNTRY,
2024–2031 (USD MILLION) 247
TABLE 234 EUROPE: PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET FOR PROTEIN FRACTIONATION & ENRICHMENT KITS, BY COUNTRY,
2024–2031 (USD MILLION) 247
TABLE 235 ASIA PACIFIC: PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET FOR PROTEIN FRACTIONATION & ENRICHMENT KITS, BY COUNTRY,
2024–2031 (USD MILLION) 248
TABLE 236 LATIN AMERICA: PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET FOR PROTEIN FRACTIONATION & ENRICHMENT KITS, BY COUNTRY,
2024–2031 (USD MILLION) 248
TABLE 237 MIDDLE EAST: PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET FOR PROTEIN FRACTIONATION & ENRICHMENT KITS, BY COUNTRY,
2024–2031 (USD MILLION) 249
TABLE 238 GCC COUNTRIES: PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET FOR PROTEIN FRACTIONATION & ENRICHMENT KITS, BY COUNTRY,
2024–2031 (USD MILLION) 249
TABLE 239 OTHER PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET,
BY REGION, 2024–2031 (USD MILLION) 250
TABLE 240 NORTH AMERICA: OTHER PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 250
TABLE 241 EUROPE: OTHER PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 251
TABLE 242 ASIA PACIFIC: OTHER PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 251
TABLE 243 LATIN AMERICA: OTHER PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 252
TABLE 244 MIDDLE EAST: OTHER PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 252
TABLE 245 GCC COUNTRIES: OTHER PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 252
TABLE 246 PROTEOMICS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY REGION, 2024–2031 (USD MILLION) 253
TABLE 247 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 254
TABLE 248 EUROPE: PROTEOMICS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 254
TABLE 249 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 255
TABLE 250 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 255
TABLE 251 MIDDLE EAST: PROTEOMICS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 255
TABLE 252 GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 256
TABLE 253 PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,
2024–2031 (USD MILLION) 258
TABLE 254 PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 259
TABLE 255 PROTEOMICS MARKET FOR SPECTROSCOPY, BY REGION,
2024–2031 (USD MILLION) 259
TABLE 256 NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2024–2031 (USD MILLION) 260
TABLE 257 EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY,
2024–2031 (USD MILLION) 260
TABLE 258 ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY,
2024–2031 (USD MILLION) 261
TABLE 259 LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2024–2031 (USD MILLION) 261
TABLE 260 MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY,
2024–2031 (USD MILLION) 262
TABLE 261 GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2024–2031 (USD MILLION) 262
TABLE 262 MASS SPECTROMETRY MARKET, BY REGION, 2024–2031 (USD MILLION) 263
TABLE 263 NORTH AMERICA: MASS SPECTROMETRY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 264
TABLE 264 EUROPE: MASS SPECTROMETRY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 264
TABLE 265 ASIA PACIFIC: MASS SPECTROMETRY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 265
TABLE 266 LATIN AMERICA: MASS SPECTROMETRY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 265
TABLE 267 MIDDLE EAST: MASS SPECTROMETRY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 265
TABLE 268 GCC COUNTRIES: MASS SPECTROMETRY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 266
TABLE 269 NMR SPECTROSCOPY MARKET, BY REGION, 2024–2031 (USD MILLION) 267
TABLE 270 NORTH AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 267
TABLE 271 EUROPE: NMR SPECTROSCOPY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 268
TABLE 272 ASIA PACIFIC: NMR SPECTROSCOPY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 268
TABLE 273 LATIN AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 269
TABLE 274 MIDDLE EAST: NMR SPECTROSCOPY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 269
TABLE 275 GCC COUNTRIES: NMR SPECTROSCOPY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 269
TABLE 276 CD SPECTROSCOPY MARKET, BY REGION, 2024–2031 (USD MILLION) 270
TABLE 277 NORTH AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 271
TABLE 278 EUROPE: CD SPECTROSCOPY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 271
TABLE 279 ASIA PACIFIC: CD SPECTROSCOPY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 272
TABLE 280 LATIN AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 272
TABLE 281 MIDDLE EAST: CD SPECTROSCOPY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 272
TABLE 282 GCC COUNTRIES: CD SPECTROSCOPY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 273
TABLE 283 PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2024–2031 (USD MILLION) 273
TABLE 284 PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY REGION,
2024–2031 (USD MILLION) 274
TABLE 285 NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2024–2031 (USD MILLION) 274
TABLE 286 EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY,
2024–2031 (USD MILLION) 275
TABLE 287 ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2024–2031 (USD MILLION) 275
TABLE 288 LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2024–2031 (USD MILLION) 276
TABLE 289 MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2024–2031 (USD MILLION) 276
TABLE 290 GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2024–2031 (USD MILLION) 276
TABLE 291 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY REGION,
2024–2031 (USD MILLION) 277
TABLE 292 NORTH AMERICA: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 278
TABLE 293 EUROPE: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 278
TABLE 294 ASIA PACIFIC: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 279
TABLE 295 LATIN AMERICA: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 279
TABLE 296 MIDDLE EAST: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 280
TABLE 297 GCC COUNTRIES: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 280
TABLE 298 ION CHROMATOGRAPHY MARKET, BY REGION, 2024–2031 (USD MILLION) 281
TABLE 299 NORTH AMERICA: ION CHROMATOGRAPHY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 281
TABLE 300 EUROPE: ION CHROMATOGRAPHY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 282
TABLE 301 ASIA PACIFIC: ION CHROMATOGRAPHY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 282
TABLE 302 LATIN AMERICA: ION CHROMATOGRAPHY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 283
TABLE 303 MIDDLE EAST: ION CHROMATOGRAPHY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 283
TABLE 304 GCC COUNTRIES: ION CHROMATOGRAPHY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 283
TABLE 305 AFFINITY CHROMATOGRAPHY MARKET, BY REGION, 2024–2031 (USD MILLION) 284
TABLE 306 NORTH AMERICA: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 285
TABLE 307 EUROPE: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 285
TABLE 308 ASIA PACIFIC: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 286
TABLE 309 LATIN AMERICA: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 286
TABLE 310 MIDDLE EAST: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 287
TABLE 311 GCC COUNTRIES: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 287
TABLE 312 SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY REGION,
2024–2031 (USD MILLION) 288
TABLE 313 NORTH AMERICA: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 288
TABLE 314 EUROPE: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 289
TABLE 315 ASIA PACIFIC: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 289
TABLE 316 LATIN AMERICA: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 290
TABLE 317 MIDDLE EAST: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 290
TABLE 318 GCC COUNTRIES: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 290
TABLE 319 PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2024–2031 (USD MILLION) 291
TABLE 320 PROTEOMICS MARKET FOR ELECTROPHORESIS, BY REGION,
2024–2031 (USD MILLION) 292
TABLE 321 NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2024–2031 (USD MILLION) 292
TABLE 322 EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY,
2024–2031 (USD MILLION) 293
TABLE 323 ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2024–2031 (USD MILLION) 293
TABLE 324 LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2024–2031 (USD MILLION) 294
TABLE 325 MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2024–2031 (USD MILLION) 294
TABLE 326 GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2024–2031 (USD MILLION) 294
TABLE 327 GEL ELECTROPHORESIS MARKET, BY REGION, 2024–2031 (USD MILLION) 295
TABLE 328 NORTH AMERICA: GEL ELECTROPHORESIS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 296
TABLE 329 EUROPE: GEL ELECTROPHORESIS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 296
TABLE 330 ASIA PACIFIC: GEL ELECTROPHORESIS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 297
TABLE 331 LATIN AMERICA: GEL ELECTROPHORESIS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 297
TABLE 332 MIDDLE EAST: GEL ELECTROPHORESIS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 298
TABLE 333 GCC COUNTRIES: GEL ELECTROPHORESIS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 298
TABLE 334 CAPILLARY ELECTROPHORESIS MARKET, BY REGION, 2024–2031 (USD MILLION) 299
TABLE 335 NORTH AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 299
TABLE 336 EUROPE: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 300
TABLE 337 ASIA PACIFIC: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 300
TABLE 338 LATIN AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 301
TABLE 339 MIDDLE EAST: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 301
TABLE 340 GCC COUNTRIES: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 301
TABLE 341 PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,
2024–2031 (USD MILLION) 302
TABLE 342 PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY REGION,
2024–2031 (USD MILLION) 303
TABLE 343 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION) 303
TABLE 344 EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION) 304
TABLE 345 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION) 304
TABLE 346 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION) 305
TABLE 347 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION) 305
TABLE 348 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION) 305
TABLE 349 INTEGRATED SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 306
TABLE 350 NORTH AMERICA: INTEGRATED SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 307
TABLE 351 EUROPE: INTEGRATED SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 307
TABLE 352 ASIA PACIFIC: INTEGRATED SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 308
TABLE 353 LATIN AMERICA: INTEGRATED SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 308
TABLE 354 MIDDLE EAST: INTEGRATED SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 308
TABLE 355 GCC COUNTRIES: INTEGRATED SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 309
TABLE 356 MICROARRAY SCANNERS MARKET, BY REGION, 2024–2031 (USD MILLION) 310
TABLE 357 NORTH AMERICA: MICROARRAY SCANNERS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 310
TABLE 358 EUROPE: MICROARRAY SCANNERS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 311
TABLE 359 ASIA PACIFIC: MICROARRAY SCANNERS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 311
TABLE 360 LATIN AMERICA: MICROARRAY SCANNERS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 312
TABLE 361 MIDDLE EAST: MICROARRAY SCANNERS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 312
TABLE 362 GCC COUNTRIES: MICROARRAY SCANNERS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 312
TABLE 363 ARRAYERS MARKET, BY REGION, 2024–2031 (USD MILLION) 313
TABLE 364 NORTH AMERICA: ARRAYERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 313
TABLE 365 EUROPE: ARRAYERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 314
TABLE 366 ASIA PACIFIC: ARRAYERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 314
TABLE 367 LATIN AMERICA: ARRAYERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 315
TABLE 368 MIDDLE EAST: ARRAYERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 315
TABLE 369 GCC COUNTRIES: ARRAYERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 315
TABLE 370 PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY REGION,
2024–2031 (USD MILLION) 316
TABLE 371 NORTH AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY,
BY COUNTRY, 2024–2031 (USD MILLION) 317
TABLE 372 EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2024–2031 (USD MILLION) 317
TABLE 373 ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2024–2031 (USD MILLION) 318
TABLE 374 LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY,
BY COUNTRY, 2024–2031 (USD MILLION) 318
TABLE 375 MIDDLE EAST: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2024–2031 (USD MILLION) 319
TABLE 376 GCC COUNTRIES: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY,
BY COUNTRY, 2024–2031 (USD MILLION) 319
TABLE 377 PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY REGION,
2024–2031 (USD MILLION) 320
TABLE 378 NORTH AMERICA: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2024–2031 (USD MILLION) 320
TABLE 379 EUROPE: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE,
BY COUNTRY, 2024–2031 (USD MILLION) 321
TABLE 380 ASIA PACIFIC: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE,
BY COUNTRY, 2024–2031 (USD MILLION) 321
TABLE 381 LATIN AMERICA: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE,
BY COUNTRY, 2024–2031 (USD MILLION) 322
TABLE 382 MIDDLE EAST: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE,
BY COUNTRY, 2024–2031 (USD MILLION) 322
TABLE 383 GCC COUNTRIES: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2024–2031 (USD MILLION) 322
TABLE 384 PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY REGION,
2024–2031 (USD MILLION) 323
TABLE 385 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION,
BY COUNTRY, 2024–2031 (USD MILLION) 324
TABLE 386 EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2024–2031 (USD MILLION) 324
TABLE 387 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2024–2031 (USD MILLION) 325
TABLE 388 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION,
BY COUNTRY, 2024–2031 (USD MILLION) 325
TABLE 389 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION,
BY COUNTRY, 2024–2031 (USD MILLION) 326
TABLE 390 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2024–2031 (USD MILLION) 326
TABLE 391 PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY REGION, 2024–2031 (USD MILLION) 327
TABLE 392 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION) 327
TABLE 393 EUROPE: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION) 328
TABLE 394 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION) 328
TABLE 395 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION) 329
TABLE 396 MIDDLE EAST: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION) 329
TABLE 397 GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION) 329
TABLE 398 PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 331
TABLE 399 CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 332
TABLE 400 CORE PROTEOMICS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 332
TABLE 401 NORTH AMERICA: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 333
TABLE 402 EUROPE: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 333
TABLE 403 ASIA PACIFIC: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 334
TABLE 404 LATIN AMERICA: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 334
TABLE 405 MIDDLE EAST: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 334
TABLE 406 GCC COUNTRIES: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 335
TABLE 407 PROTEIN IDENTIFICATION SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 336
TABLE 408 NORTH AMERICA: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 336
TABLE 409 EUROPE: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 337
TABLE 410 ASIA PACIFIC: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 337
TABLE 411 LATIN AMERICA: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 338
TABLE 412 MIDDLE EAST: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 338
TABLE 413 GCC COUNTRIES: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 338
TABLE 414 QUANTITATIVE PROTEOMICS SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 339
TABLE 415 NORTH AMERICA: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 340
TABLE 416 EUROPE: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 340
TABLE 417 ASIA PACIFIC: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 341
TABLE 418 LATIN AMERICA: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 341
TABLE 419 MIDDLE EAST: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 342
TABLE 420 GCC COUNTRIES: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 342
TABLE 421 PROTEIN CHARACTERIZATION SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 343
TABLE 422 NORTH AMERICA: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 343
TABLE 423 EUROPE: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 344
TABLE 424 ASIA PACIFIC: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 344
TABLE 425 LATIN AMERICA: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY 2024–2031 (USD MILLION) 345
TABLE 426 MIDDLE EAST: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 345
TABLE 427 GCC COUNTRIES: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 345
TABLE 428 PROTEIN PURIFICATION SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 346
TABLE 429 NORTH AMERICA: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 347
TABLE 430 EUROPE: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 347
TABLE 431 ASIA PACIFIC: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 348
TABLE 432 LATIN AMERICA: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 348
TABLE 433 MIDDLE EAST: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 349
TABLE 434 GCC COUNTRIES: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 349
TABLE 435 PROTEIN SEPARATION SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 350
TABLE 436 NORTH AMERICA: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 350
TABLE 437 EUROPE: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 351
TABLE 438 ASIA PACIFIC: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 351
TABLE 439 LATIN AMERICA: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 352
TABLE 440 MIDDLE EAST: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 352
TABLE 441 GCC COUNTRIES: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 352
TABLE 442 PROTEIN SEQUENCING SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 353
TABLE 443 NORTH AMERICA: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 354
TABLE 444 EUROPE: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 354
TABLE 445 ASIA PACIFIC: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 355
TABLE 446 LATIN AMERICA: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 355
TABLE 447 MIDDLE EAST: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 356
TABLE 448 GCC COUNTRIES: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 356
TABLE 449 CUSTOM ASSAY SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 357
TABLE 450 NORTH AMERICA: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 357
TABLE 451 EUROPE: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 358
TABLE 452 ASIA PACIFIC: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 358
TABLE 453 LATIN AMERICA: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 359
TABLE 454 MIDDLE EAST: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 359
TABLE 455 GCC COUNTRIES: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 359
TABLE 456 BIOINFORMATICS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 360
TABLE 457 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 361
TABLE 458 EUROPE: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 361
TABLE 459 ASIA PACIFIC: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 362
TABLE 460 LATIN AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 362
TABLE 461 MIDDLE EAST: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 363
TABLE 462 GCC COUNTRIES: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 363
TABLE 463 PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 365
TABLE 464 PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY REGION,
2024–2031 (USD MILLION) 366
TABLE 465 NORTH AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS,
BY COUNTRY, 2024–2031 (USD MILLION) 366
TABLE 466 EUROPE: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2024–2031 (USD MILLION) 367
TABLE 467 ASIA PACIFIC: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2024–2031 (USD MILLION) 367
TABLE 468 LATIN AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2024–2031 (USD MILLION) 368
TABLE 469 MIDDLE EAST: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2024–2031 (USD MILLION) 368
TABLE 470 GCC COUNTRIES: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2024–2031 (USD MILLION) 368
TABLE 471 PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY REGION,
2024–2031 (USD MILLION) 369
TABLE 472 NORTH AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY COUNTRY, 2024–2031 (USD MILLION) 370
TABLE 473 EUROPE: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY COUNTRY, 2024–2031 (USD MILLION) 370
TABLE 474 ASIA PACIFIC: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES,
BY COUNTRY, 2024–2031 (USD MILLION) 371
TABLE 475 LATIN AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES,
BY COUNTRY, 2024–2031 (USD MILLION) 371
TABLE 476 MIDDLE EAST: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES,
BY COUNTRY, 2024–2031 (USD MILLION) 372
TABLE 477 GCC COUNTRIES: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES,
BY COUNTRY, 2024–2031 (USD MILLION) 372
TABLE 478 PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 374
TABLE 479 PROTEOMICS MARKET FOR SAMPLE PREPARATION, BY REGION,
2024–2031 (USD MILLION) 375
TABLE 480 NORTH AMERICA: PROTEOMICS MARKET FOR SAMPLE PREPARATION,
BY COUNTRY, 2024–2031 (USD MILLION) 375
TABLE 481 EUROPE: PROTEOMICS MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION) 376
TABLE 482 ASIA PACIFIC: PROTEOMICS MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION) 376
TABLE 483 LATIN AMERICA: PROTEOMICS MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION) 377
TABLE 484 MIDDLE EAST: PROTEOMICS MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION) 377
TABLE 485 GCC COUNTRIES: PROTEOMICS MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION) 377
TABLE 486 PROTEOMICS MARKET FOR PROTEIN SEPARATION & FRACTIONATION, BY REGION, 2024–2031 (USD MILLION) 378
TABLE 487 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN SEPARATION & FRACTIONATION, BY COUNTRY, 2024–2031 (USD MILLION) 379
TABLE 488 EUROPE: PROTEOMICS MARKET FOR PROTEIN SEPARATION & FRACTIONATION,
BY COUNTRY, 2024–2031 (USD MILLION) 379
TABLE 489 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN SEPARATION & FRACTIONATION, BY COUNTRY, 2024–2031 (USD MILLION) 380
TABLE 490 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN SEPARATION & FRACTIONATION, BY COUNTRY, 2024–2031 (USD MILLION) 380
TABLE 491 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN SEPARATION & FRACTIONATION, BY COUNTRY, 2024–2031 (USD MILLION) 381
TABLE 492 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN SEPARATION & FRACTIONATION, BY COUNTRY, 2024–2031 (USD MILLION) 381
TABLE 493 PROTEOMICS MARKET FOR PROTEIN IDENTIFICATION & QUANTIFICATION, BY REGION, 2024–2031 (USD MILLION) 382
TABLE 494 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN IDENTIFICATION & QUANTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION) 382
TABLE 495 EUROPE: PROTEOMICS MARKET FOR PROTEIN IDENTIFICATION & QUANTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION) 383
TABLE 496 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN IDENTIFICATION & QUANTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION) 383
TABLE 497 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN IDENTIFICATION & QUANTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION) 384
TABLE 498 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN IDENTIFICATION & QUANTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION) 384
TABLE 499 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN IDENTIFICATION & QUANTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION) 384
TABLE 500 PROTEOMICS MARKET FOR PROTEIN CHARACTERIZATION & STRUCTURAL ANALYSIS, BY REGION, 2024–2031 (USD MILLION) 385
TABLE 501 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN CHARACTERIZATION & STRUCTURAL ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 386
TABLE 502 EUROPE: PROTEOMICS MARKET FOR PROTEIN CHARACTERIZATION & STRUCTURAL ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 386
TABLE 503 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN CHARACTERIZATION & STRUCTURAL ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 387
TABLE 504 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN CHARACTERIZATION & STRUCTURAL ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 387
TABLE 505 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN CHARACTERIZATION & STRUCTURAL ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 388
TABLE 506 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN CHARACTERIZATION & STRUCTURAL ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 388
TABLE 507 PROTEOMICS MARKET FOR BIOINFORMATICS & DATA ANALYSIS, BY REGION, 2024–2031 (USD MILLION) 389
TABLE 508 NORTH AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS & DATA ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 389
TABLE 509 EUROPE: PROTEOMICS MARKET FOR BIOINFORMATICS & DATA ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 390
TABLE 510 ASIA PACIFIC: PROTEOMICS MARKET FOR BIOINFORMATICS & DATA ANALYSIS,
BY COUNTRY, 2024–2031 (USD MILLION) 390
TABLE 511 LATIN AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS & DATA ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 391
TABLE 512 MIDDLE EAST: PROTEOMICS MARKET FOR BIOINFORMATICS & DATA ANALYSIS,
BY COUNTRY, 2024–2031 (USD MILLION) 391
TABLE 513 GCC COUNTRIES: PROTEOMICS MARKET FOR BIOINFORMATICS & DATA ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 391
TABLE 514 PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 393
TABLE 515 PROTEOMICS MARKET FOR BULK PROTEOMICS, BY REGION
2024–2031 (USD MILLION) 394
TABLE 516 NORTH AMERICA: PROTEOMICS MARKET FOR BULK PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 394
TABLE 517 EUROPE: PROTEOMICS MARKET FOR BULK PROTEOMICS, BY COUNTRY,
2024–2031 (USD MILLION) 395
TABLE 518 ASIA PACIFIC: PROTEOMICS MARKET FOR BULK PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 395
TABLE 519 LATIN AMERICA: PROTEOMICS MARKET FOR BULK PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 396
TABLE 520 MIDDLE EAST: PROTEOMICS MARKET FOR BULK PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 396
TABLE 521 GCC COUNTRIES: PROTEOMICS MARKET FOR BULK PROTEOMICS, BY COUNTRY 2024–2031 (USD MILLION) 396
TABLE 522 PROTEOMICS MARKET FOR TARGETED/AFFINITY PROTEOMICS, BY REGION, 2024–2031 (USD MILLION) 397
TABLE 523 NORTH AMERICA: PROTEOMICS MARKET FOR TARGETED/AFFINITY PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 398
TABLE 524 EUROPE: PROTEOMICS MARKET FOR TARGETED/AFFINITY PROTEOMICS,
BY COUNTRY, 2024–2031 (USD MILLION) 398
TABLE 525 ASIA PACIFIC: PROTEOMICS MARKET FOR TARGETED/AFFINITY PROTEOMICS,
BY COUNTRY, 2024–2031 (USD MILLION) 399
TABLE 526 LATIN AMERICA: PROTEOMICS MARKET FOR TARGETED/AFFINITY PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 399
TABLE 527 MIDDLE EAST: PROTEOMICS MARKET FOR TARGETED/AFFINITY PROTEOMICS,
BY COUNTRY, 2024–2031 (USD MILLION) 400
TABLE 528 GCC COUNTRIES: PROTEOMICS MARKET FOR TARGETED/AFFINITY PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 400
TABLE 529 PROTEOMICS MARKET FOR SPATIAL PROTEOMICS, BY REGION,
2024–2031 (USD MILLION) 401
TABLE 530 NORTH AMERICA: PROTEOMICS MARKET FOR SPATIAL PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 401
TABLE 531 EUROPE: PROTEOMICS MARKET FOR SPATIAL PROTEOMICS, BY COUNTRY,
2024–2031 (USD MILLION) 402
TABLE 532 ASIA PACIFIC: PROTEOMICS MARKET FOR SPATIAL PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 402
TABLE 533 LATIN AMERICA: PROTEOMICS MARKET FOR SPATIAL PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 403
TABLE 534 MIDDLE EAST: PROTEOMICS MARKET FOR SPATIAL PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 403
TABLE 535 GCC COUNTRIES: PROTEOMICS MARKET FOR SPATIAL PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 403
TABLE 536 PROTEOMICS MARKET FOR SINGLE MOLECULE PROTEOMICS/NEXT GENERATION PROTEOMICS, BY REGION, 2024–2031 (USD MILLION) 404
TABLE 537 NORTH AMERICA: PROTEOMICS MARKET FOR SINGLE MOLECULE PROTEOMICS/NEXT GENERATION PROTEOMICS, BY COUNTRY,
2024–2031 (USD MILLION) 405
TABLE 538 EUROPE: PROTEOMICS MARKET FOR SINGLE MOLECULE PROTEOMICS/NEXT GENERATION PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 405
TABLE 539 ASIA PACIFIC: PROTEOMICS MARKET FOR SINGLE MOLECULE PROTEOMICS/NEXT GENERATION PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 406
TABLE 540 LATIN AMERICA: PROTEOMICS MARKET FOR SINGLE MOLECULE PROTEOMICS/NEXT GENERATION PROTEOMICS, BY COUNTRY,
2024–2031 (USD MILLION) 406
TABLE 541 MIDDLE EAST: PROTEOMICS MARKET FOR SINGLE MOLECULE PROTEOMICS/NEXT GENERATION PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 407
TABLE 542 GCC COUNTRIES: PROTEOMICS MARKET FOR SINGLE MOLECULE PROTEOMICS/NEXT GENERATION PROTEOMICS, BY COUNTRY,
2024–2031 (USD MILLION) 407
TABLE 543 PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 409
TABLE 544 PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,
2024–2031 (USD MILLION) 410
TABLE 545 PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION,
2024–2031 (USD MILLION) 410
TABLE 546 NORTH AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS,
BY COUNTRY, 2024–2031 (USD MILLION) 411
TABLE 547 EUROPE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION) 411
TABLE 548 ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION) 412
TABLE 549 LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS,
BY COUNTRY, 2024–2031 (USD MILLION) 412
TABLE 550 MIDDLE EAST: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION) 412
TABLE 551 GCC COUNTRIES: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS,
BY COUNTRY, 2024–2031 (USD MILLION) 413
TABLE 552 CANCER CLINICAL DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 414
TABLE 553 NORTH AMERICA: CANCER CLINICAL DIAGNOSTICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 414
TABLE 554 EUROPE: CANCER CLINICAL DIAGNOSTICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 415
TABLE 555 ASIA PACIFIC: CANCER CLINICAL DIAGNOSTICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 415
TABLE 556 LATIN AMERICA: CANCER CLINICAL DIAGNOSTICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 416
TABLE 557 MIDDLE EAST: CANCER CLINICAL DIAGNOSTICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 416
TABLE 558 GCC COUNTRIES: CANCER CLINICAL DIAGNOSTICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 416
TABLE 559 INFECTIOUS DISEASE CLINICAL DIAGNOSTICS MARKET, BY REGION,
2024–2031 (USD MILLION) 417
TABLE 560 NORTH AMERICA: INFECTIOUS DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 418
TABLE 561 EUROPE: INFECTIOUS DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 418
TABLE 562 ASIA PACIFIC: INFECTIOUS DISEASE CLINICAL DIAGNOSTICS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 419
TABLE 563 LATIN AMERICA: INFECTIOUS DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 419
TABLE 564 MIDDLE EAST: INFECTIOUS DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 420
TABLE 565 GCC COUNTRIES: INFECTIOUS DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 420
TABLE 566 DIABETES CLINICAL DIAGNOSTICS MARKET, BY REGION,
2024–2031 (USD MILLION) 421
TABLE 567 NORTH AMERICA: DIABETES CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 421
TABLE 568 EUROPE: DIABETES CLINICAL DIAGNOSTICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 422
TABLE 569 ASIA PACIFIC: DIABETES CLINICAL DIAGNOSTICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 422
TABLE 570 LATIN AMERICA: DIABETES CLINICAL DIAGNOSTICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 423
TABLE 571 MIDDLE EAST: DIABETES CLINICAL DIAGNOSTICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 423
TABLE 572 GCC COUNTRIES: DIABETES CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 423
TABLE 573 NEUROLOGICAL DISORDER CLINICAL DIAGNOSTICS MARKET, BY REGION,
2024–2031 (USD MILLION) 424
TABLE 574 NORTH AMERICA: NEUROLOGICAL DISORDER CLINICAL DIAGNOSTICS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 425
TABLE 575 EUROPE: NEUROLOGICAL DISORDER CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 425
TABLE 576 ASIA PACIFIC: NEUROLOGICAL DISORDER CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 426
TABLE 577 LATIN AMERICA: NEUROLOGICAL DISORDER CLINICAL DIAGNOSTICS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 426
TABLE 578 MIDDLE EAST: NEUROLOGICAL DISORDER CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 427
TABLE 579 GCC COUNTRIES: NEUROLOGICAL DISORDER CLINICAL DIAGNOSTICS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 427
TABLE 580 AUTOIMMUNE DISEASE CLINICAL DIAGNOSTICS MARKET, BY REGION,
2024–2031 (USD MILLION) 428
TABLE 581 NORTH AMERICA: AUTOIMMUNE DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 428
TABLE 582 EUROPE: AUTOIMMUNE DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 429
TABLE 583 ASIA PACIFIC: AUTOIMMUNE DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 429
TABLE 584 LATIN AMERICA: AUTOIMMUNE DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 430
TABLE 585 MIDDLE EAST: AUTOIMMUNE DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 430
TABLE 586 GCC COUNTRIES: AUTOIMMUNE DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 430
TABLE 587 CARDIOVASCULAR DISEASE CLINICAL DIAGNOSTICS MARKET, BY REGION,
2024–2031 (USD MILLION) 431
TABLE 588 NORTH AMERICA: CARDIOVASCULAR DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 432
TABLE 589 EUROPE: CARDIOVASCULAR DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 432
TABLE 590 ASIA PACIFIC: CARDIOVASCULAR DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 433
TABLE 591 LATIN AMERICA: CARDIOVASCULAR DISEASE CLINICAL DIAGNOSTICS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 433
TABLE 592 MIDDLE EAST: CARDIOVASCULAR DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 434
TABLE 593 GCC COUNTRIES: CARDIOVASCULAR DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 434
TABLE 594 OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY REGION,
2024–2031 (USD MILLION) 435
TABLE 595 NORTH AMERICA: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 435
TABLE 596 EUROPE: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 436
TABLE 597 ASIA PACIFIC: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 436
TABLE 598 LATIN AMERICA: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 437
TABLE 599 MIDDLE EAST: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 437
TABLE 600 GCC COUNTRIES: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 437
TABLE 601 PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE,
2024–2031 (USD MILLION) 438
TABLE 602 PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION) 439
TABLE 603 NORTH AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 439
TABLE 604 EUROPE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 440
TABLE 605 ASIA PACIFIC: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 440
TABLE 606 LATIN AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 441
TABLE 607 MIDDLE EAST: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 441
TABLE 608 GCC COUNTRIES: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 441
TABLE 609 TARGET DISCOVERY MARKET, BY REGION, 2024–2031 (USD MILLION) 442
TABLE 610 NORTH AMERICA: TARGET DISCOVERY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 443
TABLE 611 EUROPE: TARGET DISCOVERY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 443
TABLE 612 ASIA PACIFIC: TARGET DISCOVERY MARKET, BY COUNTRY
, 2024–2031 (USD MILLION) 444
TABLE 613 LATIN AMERICA: TARGET DISCOVERY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 444
TABLE 614 MIDDLE EAST: TARGET DISCOVERY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 444
TABLE 615 GCC COUNTRIES: TARGET DISCOVERY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 445
TABLE 616 LEAD IDENTIFICATION MARKET, BY REGION, 2024–2031 (USD MILLION) 446
TABLE 617 NORTH AMERICA: LEAD IDENTIFICATION MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 446
TABLE 618 EUROPE: LEAD IDENTIFICATION MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 447
TABLE 619 ASIA PACIFIC: LEAD IDENTIFICATION MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 447
TABLE 620 LATIN AMERICA: LEAD IDENTIFICATION MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 448
TABLE 621 MIDDLE EAST: LEAD IDENTIFICATION MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 448
TABLE 622 GCC COUNTRIES: LEAD IDENTIFICATION MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 448
TABLE 623 LEAD OPTIMIZATION MARKET, BY REGION, 2024–2031 (USD MILLION) 449
TABLE 624 NORTH AMERICA: LEAD OPTIMIZATION MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 450
TABLE 625 EUROPE: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 450
TABLE 626 ASIA PACIFIC: LEAD OPTIMIZATION MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 451
TABLE 627 LATIN AMERICA: LEAD OPTIMIZATION MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 451
TABLE 628 MIDDLE EAST: LEAD OPTIMIZATION MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 451
TABLE 629 GCC COUNTRIES: LEAD OPTIMIZATION MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 452
TABLE 630 PRECLINICAL STUDIES MARKET, BY REGION, 2024–2031 (USD MILLION) 453
TABLE 631 NORTH AMERICA: PRECLINICAL STUDIES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 453
TABLE 632 EUROPE: PRECLINICAL STUDIES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 454
TABLE 633 ASIA PACIFIC: PRECLINICAL STUDIES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 454
TABLE 634 LATIN AMERICA: PRECLINICAL STUDIES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 455
TABLE 635 MIDDLE EAST: PRECLINICAL STUDIES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 455
TABLE 636 GCC COUNTRIES: PRECLINICAL STUDIES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 455
TABLE 637 PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY REGION,
2024–2031 (USD MILLION) 456
TABLE 638 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 457
TABLE 639 EUROPE: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY,
2024–2031 (USD MILLION) 457
TABLE 640 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 458
TABLE 641 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 458
TABLE 642 MIDDLE EAST: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 459
TABLE 643 GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 459
TABLE 644 PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 461
TABLE 645 PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY REGION, 2024–2031 (USD MILLION) 462
TABLE 646 NORTH AMERICA: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 462
TABLE 647 EUROPE: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 463
TABLE 648 ASIA PACIFIC: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES,
BY COUNTRY, 2024–2031 (USD MILLION) 463
TABLE 649 LATIN AMERICA: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 464
TABLE 650 MIDDLE EAST: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES,
BY COUNTRY, 2024–2031 (USD MILLION) 464
TABLE 651 GCC COUNTRIES: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 464
TABLE 652 PROTEOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 465
TABLE 653 NORTH AMERICA: PROTEOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 466
TABLE 654 EUROPE: PROTEOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 466
TABLE 655 ASIA PACIFIC: PROTEOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 467
TABLE 656 LATIN AMERICA: PROTEOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 467
TABLE 657 MIDDLE EAST: PROTEOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 468
TABLE 658 GCC COUNTRIES: PROTEOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 468
TABLE 659 PROTEOMICS MARKET FOR HOSPITALS, BY REGION, 2024–2031 (USD MILLION) 469
TABLE 660 NORTH AMERICA: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY,
2024–2031 (USD MILLION) 469
TABLE 661 EUROPE: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY,
2024–2031 (USD MILLION) 470
TABLE 662 ASIA PACIFIC: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY,
2024–2031 (USD MILLION) 470
TABLE 663 LATIN AMERICA: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY,
2024–2031 (USD MILLION) 471
TABLE 664 MIDDLE EAST: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY,
2024–2031 (USD MILLION) 471
TABLE 665 GCC COUNTRIES: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY,
2024–2031 (USD MILLION) 471
TABLE 666 PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY REGION,
2024–2031 (USD MILLION) 472
TABLE 667 NORTH AMERICA: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 473
TABLE 668 EUROPE: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 473
TABLE 669 ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 474
TABLE 670 LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 474
TABLE 671 MIDDLE EAST: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 475
TABLE 672 GCC COUNTRIES: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 475
TABLE 673 PROTEOMICS MARKET FOR OTHER END USERS, BY REGION,
2024–2031 (USD MILLION) 476
TABLE 674 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 476
TABLE 675 EUROPE: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY,
2024–2031 (USD MILLION) 477
TABLE 676 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 477
TABLE 677 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 478
TABLE 678 MIDDLE EAST: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 478
TABLE 679 GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 478
TABLE 680 PROTEOMICS MARKET, BY REGION, 2024–2031 (USD MILLION) 480
TABLE 681 NORTH AMERICA: PROTEOMICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 481
TABLE 682 NORTH AMERICA: PROTEOMICS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 482
TABLE 683 ASIA PACIFIC: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 482
TABLE 684 NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 483
TABLE 685 NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 483
TABLE 686 NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 484
TABLE 687 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 484
TABLE 688 NORTH AMERICA: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 485
TABLE 689 NORTH AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 485
TABLE 690 NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 486
TABLE 691 NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 486
TABLE 692 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 486
TABLE 693 NORTH AMERICA: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE,
2024–2031 (USD MILLION) 487
TABLE 694 NORTH AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 487
TABLE 695 NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 487
TABLE 696 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 488
TABLE 697 NORTH AMERICA: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 488
TABLE 698 NORTH AMERICA: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 488
TABLE 699 NORTH AMERICA: CORE PROTEOMICS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 489
TABLE 700 NORTH AMERICA: PROTEOMICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 489
TABLE 701 NORTH AMERICA: PROTEOMICS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 490
TABLE 702 NORTH AMERICA: PROTEOMICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 490
TABLE 703 NORTH AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 491
TABLE 704 NORTH AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 491
TABLE 705 NORTH AMERICA: PROTEOMICS MARKET, BY END USER,
2024–2031 (USD MILLION) 492
TABLE 706 US: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 493
TABLE 707 US: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,
2024–2031 (USD MILLION) 493
TABLE 708 US: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 494
TABLE 709 US: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2024–2031 (USD MILLION) 494
TABLE 710 US: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2024–2031 (USD MILLION) 494
TABLE 711 US: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,
2024–2031 (USD MILLION) 495
TABLE 712 US: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024–2031 (USD MILLION) 495
TABLE 713 US: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 496
TABLE 714 US: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 496
TABLE 715 US: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 497
TABLE 716 US: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 497
TABLE 717 US: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 497
TABLE 718 US: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 498
TABLE 719 US: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 498
TABLE 720 US: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 498
TABLE 721 US: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 499
TABLE 722 US: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 499
TABLE 723 US: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 500
TABLE 724 US: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 500
TABLE 725 US: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 501
TABLE 726 US: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 501
TABLE 727 US: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,
2024–2031 (USD MILLION) 502
TABLE 728 US: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 502
TABLE 729 US: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 503
TABLE 730 CANADA: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 504
TABLE 731 CANADA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,
2024–2031 (USD MILLION) 504
TABLE 732 CANADA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 505
TABLE 733 CANADA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2024–2031 (USD MILLION) 505
TABLE 734 CANADA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2024–2031 (USD MILLION) 506
TABLE 735 CANADA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,
2024–2031 (USD MILLION) 506
TABLE 736 CANADA: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024–2031 (USD MILLION) 507
TABLE 737 CANADA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 507
TABLE 738 CANADA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 508
TABLE 739 CANADA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 508
TABLE 740 CANADA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 508
TABLE 741 CANADA: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE,
2024–2031 (USD MILLION) 509
TABLE 742 CANADA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 509
TABLE 743 CANADA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 509
TABLE 744 CANADA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 510
TABLE 745 CANADA: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 510
TABLE 746 CANADA: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 510
TABLE 747 CANADA: CORE PROTEOMICS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 511
TABLE 748 CANADA: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 511
TABLE 749 CANADA: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 512
TABLE 750 CANADA: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 512
TABLE 751 CANADA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,
2024–2031 (USD MILLION) 513
TABLE 752 CANADA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 513
TABLE 753 CANADA: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 514
TABLE 754 EUROPE: PROTEOMICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 515
TABLE 755 EUROPE: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 515
TABLE 756 EUROPE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,
2024–2031 (USD MILLION) 516
TABLE 757 EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 516
TABLE 758 EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2024–2031 (USD MILLION) 517
TABLE 759 EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2024–2031 (USD MILLION) 517
TABLE 760 EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,
2024–2031 (USD MILLION) 517
TABLE 761 EUROPE: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024–2031 (USD MILLION) 518
TABLE 762 EUROPE: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 518
TABLE 763 EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 519
TABLE 764 EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 519
TABLE 765 EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 519
TABLE 766 EUROPE: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE,
2024–2031 (USD MILLION) 520
TABLE 767 EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 520
TABLE 768 EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 520
TABLE 769 EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 521
TABLE 770 EUROPE: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 521
TABLE 771 EUROPE: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 521
TABLE 772 EUROPE: CORE PROTEOMICS SERVICES MARKET, BY TYPE
, 2024–2031 (USD MILLION) 522
TABLE 773 EUROPE: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 522
TABLE 774 EUROPE: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 523
TABLE 775 EUROPE: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 523
TABLE 776 EUROPE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,
2024–2031 (USD MILLION) 524
TABLE 777 EUROPE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 524
TABLE 778 EUROPE: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 525
TABLE 779 GERMANY: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 526
TABLE 780 GERMANY: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,
2024–2031 (USD MILLION) 526
TABLE 781 GERMANY: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 527
TABLE 782 GERMANY: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2024–2031 (USD MILLION) 527
TABLE 783 GERMANY: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2024–2031 (USD MILLION) 528
TABLE 784 GERMANY: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,
2024–2031 (USD MILLION) 528
TABLE 785 GERMANY: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024–2031 (USD MILLION) 529
TABLE 786 GERMANY: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 529
TABLE 787 GERMANY: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 530
TABLE 788 GERMANY: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 530
TABLE 789 GERMANY: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 530
TABLE 790 GERMANY: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 531
TABLE 791 GERMANY: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 531
TABLE 792 GERMANY: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 531
TABLE 793 GERMANY: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 532
TABLE 794 GERMANY: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 532
TABLE 795 GERMANY: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 532
TABLE 796 GERMANY: CORE PROTEOMICS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 533
TABLE 797 GERMANY: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 533
TABLE 798 GERMANY: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 534
TABLE 799 GERMANY: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 534
TABLE 800 GERMANY: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,
2024–2031 (USD MILLION) 535
TABLE 801 GERMANY: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,
BY TYPE, 2024–2031 (USD MILLION) 535
TABLE 802 GERMANY: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 536
TABLE 804 UK: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 537
TABLE 805 UK: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,
2024–2031 (USD MILLION) 537
TABLE 807 UK: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 538
TABLE 808 UK: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2024–2031 (USD MILLION) 538
TABLE 809 UK: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2024–2031 (USD MILLION) 538
TABLE 810 UK: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,
2024–2031 (USD MILLION) 539
TABLE 811 UK: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024–2031 (USD MILLION) 539
TABLE 812 UK: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 540
TABLE 813 UK: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 540
TABLE 814 UK: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 541
TABLE 815 UK: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 541
TABLE 816 UK: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 541
TABLE 817 UK: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 542
TABLE 818 UK: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 542
TABLE 819 UK: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 542
TABLE 820 UK: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 543
TABLE 821 UK: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 543
TABLE 822 UK: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 544
TABLE 823 UK: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 544
TABLE 824 UK: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 545
TABLE 825 UK: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 545
TABLE 826 UK: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,
2024–2031 (USD MILLION) 546
TABLE 827 UK: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 546
TABLE 828 UK: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 547
TABLE 829 FRANCE: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 548
TABLE 830 FRANCE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,
2024–2031 (USD MILLION) 548
TABLE 831 FRANCE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 549
TABLE 832 FRANCE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2024–2031 (USD MILLION) 549
TABLE 833 FRANCE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2024–2031 (USD MILLION) 549
TABLE 834 FRANCE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,
2024–2031 (USD MILLION) 550
TABLE 835 FRANCE: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024–2031 (USD MILLION) 550
TABLE 836 FRANCE: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 551
TABLE 837 FRANCE: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 551
TABLE 838 FRANCE: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 552
TABLE 839 FRANCE: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 552
TABLE 840 FRANCE: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE,
2024–2031 (USD MILLION) 552
TABLE 841 FRANCE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 553
TABLE 842 FRANCE: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 553
TABLE 843 FRANCE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 553
TABLE 844 FRANCE: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 554
TABLE 845 FRANCE: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 554
TABLE 846 FRANCE: CORE PROTEOMICS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 555
TABLE 847 FRANCE: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 555
TABLE 848 FRANCE: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 556
TABLE 849 FRANCE: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 556
TABLE 850 FRANCE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,
2024–2031 (USD MILLION) 557
TABLE 851 FRANCE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,
BY TYPE, 2024–2031 (USD MILLION) 557
TABLE 852 FRANCE: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 558
TABLE 853 SWITZERLAND: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 559
TABLE 854 SWITZERLAND: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 559
TABLE 855 SWITZERLAND: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 560
TABLE 856 SWITZERLAND: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2024–2031 (USD MILLION) 560
TABLE 857 SWITZERLAND: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2024–2031 (USD MILLION) 561
TABLE 858 SWITZERLAND: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 561
TABLE 859 SWITZERLAND: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024–2031 (USD MILLION) 562
TABLE 860 SWITZERLAND: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 562
TABLE 861 SWITZERLAND: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 563
TABLE 862 SWITZERLAND: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 563
TABLE 863 SWITZERLAND: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 563
TABLE 864 SWITZERLAND: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE,
2024–2031 (USD MILLION) 564
TABLE 865 SWITZERLAND: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 564
TABLE 866 SWITZERLAND: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 564
TABLE 867 SWITZERLAND: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 565
TABLE 868 SWITZERLAND: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 565
TABLE 869 SWITZERLAND: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 565
TABLE 870 SWITZERLAND: CORE PROTEOMICS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 566
TABLE 871 SWITZERLAND: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 566
TABLE 873 SWITZERLAND: PROTEOMICS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 567
TABLE 874 SWITZERLAND: PROTEOMICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 567
TABLE 876 SWITZERLAND: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 568
TABLE 877 SWITZERLAND: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 568
TABLE 879 SWITZERLAND: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 569
TABLE 880 ITALY: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 570
TABLE 881 ITALY: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,
2024–2031 (USD MILLION) 570
TABLE 883 ITALY: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 571
TABLE 884 ITALY: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2024–2031 (USD MILLION) 571
TABLE 885 ITALY: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2024–2031 (USD MILLION) 571
TABLE 886 ITALY: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,
2024–2031 (USD MILLION) 572
TABLE 887 ITALY: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024–2031 (USD MILLION) 572
TABLE 888 ITALY: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 573
TABLE 889 ITALY: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 573
TABLE 890 ITALY: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 574
TABLE 891 ITALY: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 574
TABLE 892 ITALY: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 574
TABLE 893 ITALY: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 575
TABLE 894 ITALY: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 575
TABLE 895 ITALY: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 575
TABLE 896 ITALY: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 576
TABLE 897 ITALY: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 576
TABLE 898 ITALY: CORE PROTEOMICS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 577
TABLE 899 ITALY: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 577
TABLE 900 ITALY: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 578
TABLE 901 ITALY: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 578
TABLE 902 ITALY: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,
2024–2031 (USD MILLION) 579
TABLE 903 ITALY: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 579
TABLE 904 ITALY: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 580
TABLE 905 SPAIN: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 581
TABLE 906 SPAIN: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,
2024–2031 (USD MILLION) 581
TABLE 907 SPAIN: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 582
TABLE 908 SPAIN: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2024–2031 (USD MILLION) 582
TABLE 909 SPAIN: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2024–2031 (USD MILLION) 583
TABLE 910 SPAIN: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,
2024–2031 (USD MILLION) 583
TABLE 911 SPAIN: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024–2031 (USD MILLION) 584
TABLE 912 SPAIN: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 584
TABLE 913 SPAIN: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 585
TABLE 914 SPAIN: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 585
TABLE 915 SPAIN: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 585
TABLE 916 SPAIN: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE,
2024–2031 (USD MILLION) 586
TABLE 917 SPAIN: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 586
TABLE 918 SPAIN: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 586
TABLE 919 SPAIN: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 587
TABLE 920 SPAIN: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 587
TABLE 921 SPAIN: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 587
TABLE 922 SPAIN: CORE PROTEOMICS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 588
TABLE 923 SPAIN: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 588
TABLE 924 SPAIN: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 589
TABLE 925 SPAIN: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 589
TABLE 926 SPAIN: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,
2024–2031 (USD MILLION) 590
TABLE 927 SPAIN: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 590
TABLE 928 SPAIN: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 591
TABLE 930 REST OF EUROPE: PROTEOMICS MARKET, BY OFFERING
, 2024–2031 (USD MILLION) 592
TABLE 931 REST OF EUROPE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 592
TABLE 932 REST OF EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 593
TABLE 933 REST OF EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 593
TABLE 934 REST OF EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 594
TABLE 935 REST OF EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 594
TABLE 936 REST OF EUROPE: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 595
TABLE 937 REST OF EUROPE: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 595
TABLE 938 REST OF EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 596
TABLE 939 REST OF EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 596
TABLE 940 REST OF EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 596
TABLE 941 REST OF EUROPE: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 597
TABLE 942 REST OF EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 597
TABLE 943 REST OF EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 597
TABLE 944 REST OF EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 598
TABLE 945 REST OF EUROPE: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 598
TABLE 946 REST OF EUROPE: PROTEOMICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 598
TABLE 947 REST OF EUROPE: CORE PROTEOMICS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 599
TABLE 948 REST OF EUROPE: PROTEOMICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 599
TABLE 949 REST OF EUROPE: PROTEOMICS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 600
TABLE 950 REST OF EUROPE: PROTEOMICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 600
TABLE 952 REST OF EUROPE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 601
TABLE 953 REST OF EUROPE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 601
TABLE 954 REST OF EUROPE: PROTEOMICS MARKET, BY END USER,
2024–2031 (USD MILLION) 602
TABLE 955 ASIA PACIFIC: PROTEOMICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 603
TABLE 956 ASIA PACIFIC: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 604
TABLE 957 ASIA PACIFIC: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 604
TABLE 958 ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 605
TABLE 959 ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2024–2031 (USD MILLION) 605
TABLE 960 ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2024–2031 (USD MILLION) 606
TABLE 961 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 606
TABLE 962 ASIA PACIFIC: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024–2031 (USD MILLION) 607
TABLE 963 ASIA PACIFIC: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 607
TABLE 964 ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 608
TABLE 965 ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 608
TABLE 966 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 608
TABLE 967 ASIA PACIFIC: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE,
2024–2031 (USD MILLION) 609
TABLE 968 ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 609
TABLE 969 ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 609
TABLE 970 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 610
TABLE 971 ASIA PACIFIC: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 610
TABLE 972 ASIA PACIFIC: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 610
TABLE 973 ASIA PACIFIC: CORE PROTEOMICS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 611
TABLE 974 ASIA PACIFIC: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 611
TABLE 975 ASIA PACIFIC: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 612
TABLE 976 ASIA PACIFIC: PROTEOMICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 612
TABLE 977 ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 613
TABLE 978 ASIA PACIFIC: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,
BY TYPE, 2024–2031 (USD MILLION) 613
TABLE 979 ASIA PACIFIC: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 614
TABLE 980 CHINA: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 615
TABLE 981 CHINA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,
2024–2031 (USD MILLION) 615
TABLE 982 CHINA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 616
TABLE 983 CHINA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2024–2031 (USD MILLION) 616
TABLE 984 CHINA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2024–2031 (USD MILLION) 616
TABLE 985 CHINA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,
2024–2031 (USD MILLION) 617
TABLE 986 CHINA: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024–2031 (USD MILLION) 617
TABLE 987 CHINA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 618
TABLE 988 CHINA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 618
TABLE 989 CHINA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 619
TABLE 990 CHINA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 619
TABLE 991 CHINA: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE,
2024–2031 (USD MILLION) 619
TABLE 992 CHINA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 620
TABLE 993 CHINA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 620
TABLE 994 CHINA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 620
TABLE 995 CHINA: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 621
TABLE 996 CHINA: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 621
TABLE 997 CHINA: CORE PROTEOMICS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 622
TABLE 998 CHINA: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 622
TABLE 999 CHINA: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 623
TABLE 1000 CHINA: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 623
TABLE 1001 CHINA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,
2024–2031 (USD MILLION) 624
TABLE 1002 CHINA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 624
TABLE 1003 CHINA: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 625
TABLE 1004 JAPAN: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 626
TABLE 1005 JAPAN: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,
2024–2031 (USD MILLION) 626
TABLE 1006 JAPAN: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 627
TABLE 1007 JAPAN: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2024–2031 (USD MILLION) 627
TABLE 1008 JAPAN: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2024–2031 (USD MILLION) 628
TABLE 1009 JAPAN: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,
2024–2031 (USD MILLION) 628
TABLE 1010 JAPAN: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024–2031 (USD MILLION) 629
TABLE 1011 JAPAN: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 629
TABLE 1012 JAPAN: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 630
TABLE 1013 JAPAN: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 630
TABLE 1014 JAPAN: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 630
TABLE 1015 JAPAN: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE,
2024–2031 (USD MILLION) 631
TABLE 1016 JAPAN: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 631
TABLE 1017 JAPAN: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 631
TABLE 1018 JAPAN: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 632
TABLE 1019 JAPAN: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 632
TABLE 1020 JAPAN: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 632
TABLE 1021 JAPAN: CORE PROTEOMICS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 633
TABLE 1022 JAPAN: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 633
TABLE 1023 JAPAN: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 634
TABLE 1024 JAPAN: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 634
TABLE 1025 JAPAN: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,
2024–2031 (USD MILLION) 635
TABLE 1026 JAPAN: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 635
TABLE 1027 JAPAN: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 636
TABLE 1028 INDIA: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 637
TABLE 1029 INDIA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,
2024–2031 (USD MILLION) 637
TABLE 1030 INDIA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 638
TABLE 1031 INDIA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2024–2031 (USD MILLION) 638
TABLE 1032 INDIA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2024–2031 (USD MILLION) 639
TABLE 1033 INDIA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,
2024–2031 (USD MILLION) 639
TABLE 1034 INDIA: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024–2031 (USD MILLION) 640
TABLE 1035 INDIA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 640
TABLE 1036 INDIA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 641
TABLE 1037 INDIA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 641
TABLE 1038 INDIA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 641
TABLE 1039 INDIA: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 642
TABLE 1040 INDIA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 642
TABLE 1041 INDIA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 642
TABLE 1042 INDIA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 643
TABLE 1043 INDIA: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 643
TABLE 1044 INDIA: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 643
TABLE 1045 INDIA: CORE PROTEOMICS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 644
TABLE 1046 INDIA: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 644
TABLE 1047 INDIA: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 645
TABLE 1048 INDIA: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 645
TABLE 1049 INDIA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,
2024–2031 (USD MILLION) 646
TABLE 1050 INDIA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 646
TABLE 1051 INDIA: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 647
TABLE 1052 SOUTH KOREA: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 648
TABLE 1053 SOUTH KOREA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 648
TABLE 1054 SOUTH KOREA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 649
TABLE 1055 SOUTH KOREA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2024–2031 (USD MILLION) 649
TABLE 1056 SOUTH KOREA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2024–2031 (USD MILLION) 650
TABLE 1057 SOUTH KOREA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 650
TABLE 1058 SOUTH KOREA: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024–2031 (USD MILLION) 651
TABLE 1059 SOUTH KOREA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 651
TABLE 1060 SOUTH KOREA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 652
TABLE 1061 SOUTH KOREA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 652
TABLE 1062 SOUTH KOREA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 652
TABLE 1063 SOUTH KOREA: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE,
2024–2031 (USD MILLION) 653
TABLE 1064 SOUTH KOREA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 653
TABLE 1065 SOUTH KOREA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 653
TABLE 1066 SOUTH KOREA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 654
TABLE 1067 SOUTH KOREA: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 654
TABLE 1068 SOUTH KOREA: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 654
TABLE 1069 SOUTH KOREA: CORE PROTEOMICS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 655
TABLE 1070 SOUTH KOREA: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 655
TABLE 1071 SOUTH KOREA: PROTEOMICS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 656
TABLE 1072 SOUTH KOREA: PROTEOMICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 656
TABLE 1073 SOUTH KOREA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 657
TABLE 1074 SOUTH KOREA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 657
TABLE 1075 SOUTH KOREA: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 658
TABLE 1076 AUSTRALIA: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 659
TABLE 1077 AUSTRALIA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,
2024–2031 (USD MILLION) 659
TABLE 1078 AUSTRALIA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 660
TABLE 1079 AUSTRALIA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2024–2031 (USD MILLION) 660
TABLE 1080 AUSTRALIA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2024–2031 (USD MILLION) 661
TABLE 1081 AUSTRALIA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,
2024–2031 (USD MILLION) 661
TABLE 1082 AUSTRALIA: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024–2031 (USD MILLION) 662
TABLE 1083 AUSTRALIA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 662
TABLE 1084 AUSTRALIA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 663
TABLE 1085 AUSTRALIA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 663
TABLE 1086 AUSTRALIA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 663
TABLE 1087 AUSTRALIA: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 664
TABLE 1088 AUSTRALIA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 664
TABLE 1089 AUSTRALIA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 664
TABLE 1090 AUSTRALIA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 665
TABLE 1091 AUSTRALIA: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 665
TABLE 1092 AUSTRALIA: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 665
TABLE 1093 AUSTRALIA: CORE PROTEOMICS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 666
TABLE 1094 AUSTRALIA: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 666
TABLE 1095 AUSTRALIA: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 667
TABLE 1096 AUSTRALIA: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 667
TABLE 1097 AUSTRALIA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,
2024–2031 (USD MILLION) 668
TABLE 1098 AUSTRALIA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,
BY TYPE, 2024–2031 (USD MILLION) 668
TABLE 1099 AUSTRALIA: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 669
TABLE 1100 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 669
TABLE 1101 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 670
TABLE 1102 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 670
TABLE 1103 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 671
TABLE 1104 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 671
TABLE 1105 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 671
TABLE 1106 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 672
TABLE 1107 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 672
TABLE 1108 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 673
TABLE 1109 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 673
TABLE 1110 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 673
TABLE 1111 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE,
2024–2031 (USD MILLION) 674
TABLE 1112 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 674
TABLE 1113 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 674
TABLE 1114 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 675
TABLE 1115 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY TYPE,
2024–2031 (USD MILLION) 675
TABLE 1116 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 675
TABLE 1117 REST OF ASIA PACIFIC: CORE PROTEOMICS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 676
TABLE 1118 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 676
TABLE 1119 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 677
TABLE 1120 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 677
TABLE 1121 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 678
TABLE 1122 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 678
TABLE 1123 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY END USER,
2024–2031 (USD MILLION) 679
TABLE 1124 LATIN AMERICA: PROTEOMICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 679
TABLE 1125 LATIN AMERICA: PROTEOMICS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 680
TABLE 1126 LATIN AMERICA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 680
TABLE 1127 LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 681
TABLE 1128 LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2024–2031 (USD MILLION) 681
TABLE 1129 LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2024–2031 (USD MILLION) 682
TABLE 1130 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 682
TABLE 1131 LATIN AMERICA: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024–2031 (USD MILLION) 683
TABLE 1132 LATIN AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 683
TABLE 1133 LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 684
TABLE 1134 LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 684
TABLE 1135 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 684
TABLE 1136 LATIN AMERICA: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE,
2024–2031 (USD MILLION) 685
TABLE 1137 LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 685
TABLE 1138 LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 685
TABLE 1139 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 686
TABLE 1140 LATIN AMERICA: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 686
TABLE 1141 LATIN AMERICA: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 686
TABLE 1142 LATIN AMERICA: CORE PROTEOMICS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 687
TABLE 1143 LATIN AMERICA: PROTEOMICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 687
TABLE 1144 LATIN AMERICA: PROTEOMICS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 688
TABLE 1145 LATIN AMERICA: PROTEOMICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 688
TABLE 1146 LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 689
TABLE 1147 LATIN AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 689
TABLE 1148 LATIN AMERICA: PROTEOMICS MARKET, BY END USER,
2024–2031 (USD MILLION) 690
TABLE 1149 BRAZIL: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 691
TABLE 1150 BRAZIL: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,
2024–2031 (USD MILLION) 691
TABLE 1151 BRAZIL: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 692
TABLE 1152 BRAZIL: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2024–2031 (USD MILLION) 692
TABLE 1153 BRAZIL: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2024–2031 (USD MILLION) 692
TABLE 1154 BRAZIL: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,
2024–2031 (USD MILLION) 693
TABLE 1155 BRAZIL: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024–2031 (USD MILLION) 693
TABLE 1156 BRAZIL: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 694
TABLE 1157 BRAZIL: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 694
TABLE 1158 BRAZIL: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 695
TABLE 1159 BRAZIL: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 695
TABLE 1160 BRAZIL: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE,
2024–2031 (USD MILLION) 695
TABLE 1161 BRAZIL: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 696
TABLE 1162 BRAZIL: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 696
TABLE 1163 BRAZIL: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 696
TABLE 1164 BRAZIL: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 697
TABLE 1165 BRAZIL: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 697
TABLE 1166 BRAZIL: CORE PROTEOMICS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 698
TABLE 1167 BRAZIL: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 698
TABLE 1168 BRAZIL: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 699
TABLE 1169 BRAZIL: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 699
TABLE 1170 BRAZIL: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,
2024–2031 (USD MILLION) 700
TABLE 1171 BRAZIL: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 700
TABLE 1172 BRAZIL: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 701
TABLE 1173 MEXICO: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 702
TABLE 1174 MEXICO: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,
2024–2031 (USD MILLION) 702
TABLE 1175 MEXICO: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 703
TABLE 1176 MEXICO: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2024–2031 (USD MILLION) 703
TABLE 1177 MEXICO: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2024–2031 (USD MILLION) 704
TABLE 1178 MEXICO: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,
2024–2031 (USD MILLION) 704
TABLE 1179 MEXICO: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024–2031 (USD MILLION) 705
TABLE 1180 MEXICO: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 705
TABLE 1181 MEXICO: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 706
TABLE 1182 MEXICO: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 706
TABLE 1183 MEXICO: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 706
TABLE 1184 MEXICO: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE,
2024–2031 (USD MILLION) 707
TABLE 1185 MEXICO: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 707
TABLE 1186 MEXICO: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 707
TABLE 1187 MEXICO: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 708
TABLE 1188 MEXICO: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 708
TABLE 1189 MEXICO: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 708
TABLE 1190 MEXICO: CORE PROTEOMICS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 709
TABLE 1191 MEXICO: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 709
TABLE 1192 MEXICO: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 710
TABLE 1193 MEXICO: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 710
TABLE 1194 MEXICO: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,
2024–2031 (USD MILLION) 711
TABLE 1195 MEXICO: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,
BY TYPE, 2024–2031 (USD MILLION) 711
TABLE 1196 MEXICO: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 712
TABLE 1197 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 713
TABLE 1198 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 713
TABLE 1199 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 714
TABLE 1200 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY,
BY TYPE, 2024–2031 (USD MILLION) 714
TABLE 1201 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 715
TABLE 1202 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 715
TABLE 1203 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 716
TABLE 1204 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 716
TABLE 1205 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 717
TABLE 1206 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 717
TABLE 1207 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 717
TABLE 1208 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE,
2024–2031 (USD MILLION) 718
TABLE 1209 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 718
TABLE 1210 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 718
TABLE 1211 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 719
TABLE 1212 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY TYPE,
2024–2031 (USD MILLION) 719
TABLE 1213 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 719
TABLE 1214 REST OF LATIN AMERICA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 720
TABLE 1215 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 720
TABLE 1216 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 721
TABLE 1217 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 721
TABLE 1218 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 722
TABLE 1219 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 722
TABLE 1220 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY END USER,
2024–2031 (USD MILLION) 723
TABLE 1221 MIDDLE EAST: PROTEOMICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 723
TABLE 1222 MIDDLE EAST: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 724
TABLE 1223 MIDDLE EAST: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 724
TABLE 1224 MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 725
TABLE 1225 MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2024–2031 (USD MILLION) 725
TABLE 1226 MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2024–2031 (USD MILLION) 726
TABLE 1227 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 726
TABLE 1228 MIDDLE EAST: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024–2031 (USD MILLION) 727
TABLE 1229 MIDDLE EAST: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 727
TABLE 1230 MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 728
TABLE 1231 MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 728
TABLE 1232 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 728
TABLE 1233 MIDDLE EAST: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE,
2024–2031 (USD MILLION) 729
TABLE 1234 MIDDLE EAST: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 729
TABLE 1235 MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 729
TABLE 1236 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 730
TABLE 1237 MIDDLE EAST: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 730
TABLE 1238 MIDDLE EAST: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 730
TABLE 1239 MIDDLE EAST: CORE PROTEOMICS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 731
TABLE 1240 MIDDLE EAST: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 731
TABLE 1241 MIDDLE EAST: PROTEOMICS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 732
TABLE 1242 MIDDLE EAST: PROTEOMICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 732
TABLE 1243 MIDDLE EAST: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 733
TABLE 1244 MIDDLE EAST: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 733
TABLE 1245 MIDDLE EAST: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 734
TABLE 1246 GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2024–2031 (USD MILLION) 734
TABLE 1247 GCC COUNTRIES: PROTEOMICS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 735
TABLE 1248 GCC COUNTRIES: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 735
TABLE 1249 GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 736
TABLE 1250 GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 736
TABLE 1251 GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 737
TABLE 1252 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 737
TABLE 1253 GCC COUNTRIES: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024–2031 (USD MILLION) 738
TABLE 1254 GCC COUNTRIES: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 738
TABLE 1255 GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 739
TABLE 1256 GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 739
TABLE 1257 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 739
TABLE 1258 GCC COUNTRIES: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE,
2024–2031 (USD MILLION) 740
TABLE 1259 GCC COUNTRIES: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 740
TABLE 1260 GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 740
TABLE 1261 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 741
TABLE 1262 GCC COUNTRIES: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 741
TABLE 1263 GCC COUNTRIES: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 741
TABLE 1264 GCC COUNTRIES: CORE PROTEOMICS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 742
TABLE 1265 GCC COUNTRIES: PROTEOMICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 742
TABLE 1266 GCC COUNTRIES: PROTEOMICS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 743
TABLE 1267 GCC COUNTRIES: PROTEOMICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 743
TABLE 1268 GCC COUNTRIES: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 744
TABLE 1269 GCC COUNTRIES: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 744
TABLE 1270 GCC COUNTRIES: PROTEOMICS MARKET, BY END USER,
2024–2031 (USD MILLION) 745
TABLE 1271 SAUDI ARABIA: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 746
TABLE 1272 SAUDI ARABIA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 746
TABLE 1273 SAUDI ARABIA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 747
TABLE 1274 SAUDI ARABIA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2024–2031 (USD MILLION) 747
TABLE 1275 SAUDI ARABIA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2024–2031 (USD MILLION) 748
TABLE 1276 SAUDI ARABIA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 748
TABLE 1277 SAUDI ARABIA: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024–2031 (USD MILLION) 749
TABLE 1278 SAUDI ARABIA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 749
TABLE 1279 SAUDI ARABIA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 750
TABLE 1280 SAUDI ARABIA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 750
TABLE 1281 SAUDI ARABIA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 750
TABLE 1282 SAUDI ARABIA: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE,
2024–2031 (USD MILLION) 751
TABLE 1283 SAUDI ARABIA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 751
TABLE 1284 SAUDI ARABIA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 751
TABLE 1285 SAUDI ARABIA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 752
TABLE 1286 SAUDI ARABIA: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 752
TABLE 1287 SAUDI ARABIA: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 752
TABLE 1288 SAUDI ARABIA: CORE PROTEOMICS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 753
TABLE 1289 SAUDI ARABIA: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 753
TABLE 1290 SAUDI ARABIA: PROTEOMICS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 754
TABLE 1291 SAUDI ARABIA: PROTEOMICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 754
TABLE 1292 SAUDI ARABIA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 755
TABLE 1293 SAUDI ARABIA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 755
TABLE 1294 SAUDI ARABIA: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 756
TABLE 1295 UAE: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 757
TABLE 1296 UAE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,
2024–2031 (USD MILLION) 757
TABLE 1297 UAE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 758
TABLE 1298 UAE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2024–2031 (USD MILLION) 758
TABLE 1299 UAE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2024–2031 (USD MILLION) 758
TABLE 1300 UAE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,
2024–2031 (USD MILLION) 759
TABLE 1301 UAE: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024–2031 (USD MILLION) 759
TABLE 1302 UAE: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES,
BY TYPE, 2024–2031 (USD MILLION) 760
TABLE 1303 UAE: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES,
BY TYPE, 2024–2031 (USD MILLION) 760
TABLE 1304 UAE: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 761
TABLE 1305 UAE: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 761
TABLE 1306 UAE: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 761
TABLE 1307 UAE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 762
TABLE 1308 UAE: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 762
TABLE 1309 UAE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 762
TABLE 1310 UAE: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 763
TABLE 1311 UAE: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 763
TABLE 1312 UAE: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 764
TABLE 1313 UAE: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 764
TABLE 1314 UAE: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 765
TABLE 1315 UAE: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 765
TABLE 1316 UAE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,
2024–2031 (USD MILLION) 766
TABLE 1317 UAE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 766
TABLE 1318 UAE: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 767
TABLE 1319 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 768
TABLE 1320 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 768
TABLE 1321 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 769
TABLE 1322 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 769
TABLE 1323 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS,
BY TYPE, 2024–2031 (USD MILLION) 770
TABLE 1324 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS,
BY TYPE, 2024–2031 (USD MILLION) 770
TABLE 1325 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 771
TABLE 1326 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 771
TABLE 1327 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 772
TABLE 1328 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 772
TABLE 1329 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 772
TABLE 1330 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE,
2024–2031 (USD MILLION) 773
TABLE 1331 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 773
TABLE 1332 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 773
TABLE 1333 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 774
TABLE 1334 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY TYPE
, 2024–2031 (USD MILLION) 774
TABLE 1335 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 774
TABLE 1336 REST OF GCC COUNTRIES: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 775
TABLE 1337 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 775
TABLE 1338 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 776
TABLE 1339 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 776
TABLE 1340 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 777
TABLE 1341 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 777
TABLE 1342 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY END USER,
2024–2031 (USD MILLION) 778
TABLE 1343 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 779
TABLE 1344 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 779
TABLE 1345 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 780
TABLE 1346 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 780
TABLE 1347 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 781
TABLE 1348 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS,
BY TYPE, 2024–2031 (USD MILLION) 781
TABLE 1349 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 782
TABLE 1350 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 782
TABLE 1351 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 783
TABLE 1352 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 783
TABLE 1353 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 783
TABLE 1354 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE,
2024–2031 (USD MILLION) 784
TABLE 1355 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 784
TABLE 1356 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 784
TABLE 1357 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 785
TABLE 1358 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY TYPE,
2024–2031 (USD MILLION) 785
TABLE 1359 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 785
TABLE 1360 REST OF MIDDLE EAST: CORE PROTEOMICS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 786
TABLE 1361 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 786
TABLE 1362 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 787
TABLE 1363 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 787
TABLE 1364 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 788
TABLE 1365 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 788
TABLE 1366 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY END USER,
2024–2031 (USD MILLION) 789
TABLE 1367 AFRICA: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 790
TABLE 1368 AFRICA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,
2024–2031 (USD MILLION) 790
TABLE 1369 AFRICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,
2024–2031 (USD MILLION) 791
TABLE 1370 AFRICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2024–2031 (USD MILLION) 791
TABLE 1371 AFRICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2024–2031 (USD MILLION) 792
TABLE 1372 AFRICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,
2024–2031 (USD MILLION) 792
TABLE 1373 AFRICA: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024–2031 (USD MILLION) 793
TABLE 1374 AFRICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 793
TABLE 1375 AFRICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 794
TABLE 1376 AFRICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 794
TABLE 1377 AFRICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 794
TABLE 1378 AFRICA: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE,
2024–2031 (USD MILLION) 795
TABLE 1379 AFRICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 795
TABLE 1380 AFRICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 795
TABLE 1381 AFRICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 796
TABLE 1382 AFRICA: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 796
TABLE 1383 AFRICA: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 796
TABLE 1384 AFRICA: CORE PROTEOMICS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 797
TABLE 1385 AFRICA: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 797
TABLE 1386 AFRICA: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 798
TABLE 1387 AFRICA: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 798
TABLE 1388 AFRICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,
2024–2031 (USD MILLION) 799
TABLE 1389 AFRICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 799
TABLE 1390 AFRICA: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 800
TABLE 1391 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN PROTEOMICS MARKET, JANUARY 2023-APRIL 2026 801
TABLE 1392 PROTEOMICS MARKET: DEGREE OF COMPETITION 805
TABLE 1393 PROTEOMICS MARKET: REGION FOOTPRINT 811
TABLE 1394 PROTEOMICS MARKET: INSTRUMENTATION TECHNOLOGY FOOTPRINT 812
TABLE 1395 PROTEOMICS MARKET: REAGENT FOOTPRINT 813
TABLE 1396 PROTEOMICS MARKET: SERVICE FOOTPRINT 815
TABLE 1397 PROTEOMICS MARKET: SOFTWARE FOOTPRINT 816
TABLE 1398 PROTEOMICS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 819
TABLE 1399 PROTEOMICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 820
TABLE 1400 PROTEOMICS MARKET: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 822
TABLE 1401 PROTEOMICS MARKET: DEALS, JANUARY 2023–APRIL 2026 823
TABLE 1402 PROTEOMICS MARKET: EXPANSIONS, JANUARY 2023–APRIL 2026 824
TABLE 1403 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 825
TABLE 1404 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 826
TABLE 1405 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES,
JANUARY 2023–APRIL 2026 839
TABLE 1406 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023–APRIL 2026 840
TABLE 1407 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 841
TABLE 1408 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 842
TABLE 1409 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 847
TABLE 1410 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023–APRIL 2026 848
TABLE 1411 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2023-APRIL 2026 849
TABLE 1412 MERCK KGAA: COMPANY OVERVIEW 850
TABLE 1413 MERCK KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 851
TABLE 1414 MERCK KGAA: DEALS, JANUARY 2023-APRIL 2026 854
TABLE 1415 DANAHER CORPORATION: COMPANY OVERVIEW 855
TABLE 1416 DANAHER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 856
TABLE 1417 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 868
TABLE 1418 DANAHER CORPORATION: DEALS, JANUARY 2023–APRIL 2026 869
TABLE 1419 SHIMADZU CORPORATION: COMPANY OVERVIEW 870
TABLE 1420 SHIMADZU CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 871
TABLE 1421 SHIMADZU CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 876
TABLE 1422 SHIMADZU CORPORATION: EXPANSIONS, JANUARY 2023–APRIL 2026 876
TABLE 1423 WATERS CORPORATION: COMPANY OVERVIEW 878
TABLE 1424 WATERS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 879
TABLE 1425 WATERS CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 886
TABLE 1426 WATERS CORPORATION: DEALS, JANUARY 2023–APRIL 2026 886
TABLE 1427 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 887
TABLE 1428 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 888
TABLE 1429 BRUKER: COMPANY OVERVIEW 897
TABLE 1430 BRUKER: PRODUCTS/SERVICES/SOLUTIONS OFFERED 898
TABLE 1431 BRUKER: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 904
TABLE 1432 BRUKER: DEALS, JANUARY 2023–APRIL 2026 905
TABLE 1433 REVVITY: COMPANY OVERVIEW 906
TABLE 1434 REVVITY: PRODUCTS/SERVICES/SOLUTIONS OFFERED 907
TABLE 1435 REVVITY: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 910
TABLE 1436 ILLUMINA, INC.: COMPANY OVERVIEW 911
TABLE 1437 ILLUMINA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 912
TABLE 1438 ILLUMINA, INC.: DEALS, JANUARY 2023–APRIL 2026 914
TABLE 1439 PROMEGA CORPORATION: COMPANY OVERVIEW 915
TABLE 1440 PROMEGA CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 915
TABLE 1441 EUROFINS SCIENTIFIC: COMPANY OVERVIEW 919
TABLE 1442 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 920
TABLE 1443 EUROFINS SCIENTIFIC: DEALS, JANUARY 2023–APRIL 2026 921
TABLE 1444 QIAGEN: COMPANY OVERVIEW 922
TABLE 1445 QIAGEN: PRODUCTS/SERVICES/SOLUTIONS OFFERED 923
TABLE 1446 QIAGEN: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 926
TABLE 1447 QIAGEN: DEALS, JANUARY 2023–APRIL 2026 927
TABLE 1448 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW 928
TABLE 1449 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED 929
TABLE 1450 CHARLES RIVER LABORATORIES: PRODUCT LAUNCHES,
JANUARY 2023–APRIL 2026 931
TABLE 1451 CHARLES RIVER LABORATORIES: DEALS, JANUARY 2023–APRIL 2026 932
TABLE 1452 PROTAGENE: COMPANY OVERVIEW 933
TABLE 1453 PROTAGENE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 933
TABLE 1454 BIO-TECHNE: COMPANY OVERVIEW 936
TABLE 1455 BIO-TECHNE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 937
TABLE 1456 AZENTA US INC.: COMPANY OVERVIEW 939
TABLE 1457 AZENTA US INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 940
TABLE 1458 QUANTERIX: COMPANY OVERVIEW 941
TABLE 1459 QUANTERIX: PRODUCTS/SERVICES/SOLUTIONS OFFERED 942
TABLE 1460 PROTEOMICS INTERNATIONAL: COMPANY OVERVIEW 943
TABLE 1461 PROTEOMICS INTERNATIONAL: PRODUCTS/SERVICES/SOLUTIONS OFFERED 944
TABLE 1462 HAMILTON COMPANY: COMPANY OVERVIEW 945
TABLE 1463 HAMILTON COMPANY: PRODUCTS/SERVICES/SOLUTIONS OFFERED 945
TABLE 1464 HAMILTON COMPANY: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 946
TABLE 1465 CREATIVE PROTEOMICS: COMPANY OVERVIEW 947
TABLE 1466 HORIBA, LTD.: COMPANY OVERVIEW 949
TABLE 1467 LABVANTAGE-BIOMAX GMBH: COMPANY OVERVIEW 950
TABLE 1468 FIOS GENOMICS: COMPANY OVERVIEW 951
TABLE 1469 MEDGENOME: COMPANY OVERVIEW 952
TABLE 1470 BIOGNOSYS AG: COMPANY OVERVIEW 953
TABLE 1471 MACROGEN, INC.: COMPANY OVERVIEW 954
TABLE 1472 CELL SIGNALING TECHNOLOGY, INC.: COMPANY OVERVIEW 955
TABLE 1473 STANDARD BIOTOOLS: COMPANY OVERVIEW 956
TABLE 1474 PIXELGEN TECHNOLOGIES: COMPANY OVERVIEW 957
TABLE 1475 APPLIED BIOMICS: COMPANY OVERVIEW 957
TABLE 1476 QUANTUM-SI INCORPORATED: COMPANY OVERVIEW 958
TABLE 1477 ERISYON INC.: COMPANY OVERVIEW 959
TABLE 1478 NAUTILUS BIOTECHNOLOGY, INC.: COMPANY OVERVIEW 960
TABLE 1479 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 972
TABLE 1480 RISK ASSESSMENT 973

LIST OF FIGURES

FIGURE 1 PROTEOMICS MARKET SEGMENTATION AND REGIONS CONSIDERED 79
FIGURE 2 PROTEOMICS MARKET: YEARS CONSIDERED 81
FIGURE 3 MARKET SCENARIO 83
FIGURE 4 GLOBAL PROTEOMICS MARKET, 2024–2031 84
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PROTEOMICS MARKET,
2023–2026 84
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF PROTEOMICS MARKET 85
FIGURE 7 HIGH-GROWTH SEGMENTS IN PROTEOMICS MARKET, 2026–2031 86
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN PROTEOMICS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 87
FIGURE 9 ADVANCEMENTS HIGH-THROUGHPUT MASS SPECTROMETRY TO DRIVE MARKET GROWTH 88
FIGURE 10 CORE PROTEOMICS SERVICES ACCOUNTED FOR LARGEST SHARE OF PROTEOMICS MARKET IN NORTH AMERICA IN 2025 89
FIGURE 11 ASIA PACIFIC IS LIKELY TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD 89
FIGURE 12 CLINICAL DIAGNOSTICS TO DOMINATE MARKET DURING FORECAST PERIOD 90
FIGURE 13 PROTEOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 92
FIGURE 14 PROTEOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS 100
FIGURE 15 VALUE CHAIN ANALYSIS 104
FIGURE 16 PROTEOMICS MARKET: ECOSYSTEM ANALYSIS 106
FIGURE 17 AVERAGE SELLING PRICE OF INSTRUMENTATION, BY KEY PLAYER, 2025 (USD) 108
FIGURE 18 AVERAGE SELLING PRICE OF REAGENTS, BY KEY PLAYER, 2025 (USD) 109
FIGURE 19 AVERAGE SELLING PRICE OF INSTRUMENTATION, BY REGION, 2025 (USD) 110
FIGURE 20 AVERAGE SELLING PRICE OF REAGENTS, BY REGION, 2025 (USD) 110
FIGURE 21 PROTEOMICS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 115
FIGURE 22 INVESTMENT AND FUNDING SCENARIO, 2023–2025 (USD MILLION) 116
FIGURE 23 PATENT APPLICATIONS IN PROTEOMICS MARKET,
JANUARY 2015- DECEMBER 2025 134
FIGURE 24 IMPACT OF AI/GEN AI ON THE PROTEOMICS MARKET 136
FIGURE 25 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 140
FIGURE 26 KEY BUYING CRITERIA, BY END USER 141
FIGURE 27 NORTH AMERICA: PROTEOMICS MARKET SNAPSHOT 481
FIGURE 28 ASIA PACIFIC: PROTEOMICS MARKET SNAPSHOT 603
FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN PROTEOMICS MARKET,
2021–2025 (USD MILLION) 803
FIGURE 30 MARKET SHARE ANALYSIS, 2025 804
FIGURE 31 PROTEOMICS MARKET: BRAND COMPARATIVE ANALYSIS 807
FIGURE 32 PROTEOMICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 809
FIGURE 33 PROTEOMICS MARKET: COMPANY FOOTPRINT 810
FIGURE 34 PROTEOMICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 818
FIGURE 35 YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA OF KEY VENDORS 821
FIGURE 36 EV/EBITDA OF KEY VENDORS 822
FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 826
FIGURE 38 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025) 842
FIGURE 39 MERCK KGAA: COMPANY SNAPSHOT (2025) 851
FIGURE 40 DANAHER CORPORATION: COMPANY SNAPSHOT (2025) 856
FIGURE 41 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2024) 871
FIGURE 42 WATERS CORPORATION: COMPANY SNAPSHOT (2025) 879
FIGURE 43 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025) 888
FIGURE 44 BRUKER: COMPANY SNAPSHOT (2025) 898
FIGURE 45 REVVITY: COMPANY SNAPSHOT (2025) 907
FIGURE 46 ILLUMINA, INC.: COMPANY SNAPSHOT (2025) 912
FIGURE 47 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2025) 920
FIGURE 48 QIAGEN: COMPANY SNAPSHOT (2025) 923
FIGURE 49 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2025) 929
FIGURE 50 BIO-TECHNE: COMPANY SNAPSHOT (2025) 937
FIGURE 51 AZENTA US INC.: COMPANY SNAPSHOT (2025) 940
FIGURE 52 QUANTERIX: COMPANY SNAPSHOT (2025) 941
FIGURE 53 PROTEOMICS INTERNATIONAL: COMPANY SNAPSHOT (2025) 943
FIGURE 54 PROTEOMICS MARKET: RESEARCH DESIGN 961
FIGURE 55 PROTEOMICS MARKET: BREAKDOWN OF PRIMARIES 963
FIGURE 56 PROTEOMICS MARKET: INSIGHTS FROM PRIMARIES 964
FIGURE 57 GLOBAL PROTEOMICS MARKET ESTIMATION, 2025 965
FIGURE 58 PROTEOMICS MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH) (2025) 966
FIGURE 59 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE ANALYSIS (2025) 966
FIGURE 60 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 967
FIGURE 61 PROTEOMICS MARKET: CAGR PROJECTIONS 970
FIGURE 62 PROTEOMICS MARKET: DATA TRIANGULATION 971

---

---